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 Next-generation sequencing (NGS) of host-associated microbes has revolutionized our 
understanding of commensal microbiota diversity and their interaction with the host to influence 
health and disease. The purpose of this work was at first descriptive, to undertake the founding 
studies using NGS to describe the cutaneous fungal microbiota (mycobiota) of dogs and cats, and 
to investigate alterations in allergic animals. The final study investigated the species level 
distribution and temporality of one fungal commensal, Malassezia, owing to its role in secondary 
yeast dermatitis of allergic dogs. A greater diversity of fungi was sequenced from skin swabs 
than was previously described using culture-dependent methods. The cutaneous mycobiota was 
predominated by environmental fungi and was more diverse on haired body sites than mucosal 
sites. The skin of allergic dogs harbored fewer types of fungi compared to healthy controls and a 
fungal dysbiosis was identified in allergic dogs and cats. Further analysis revealed a species level 
dysbiosis of Malassezia with significantly more M. restricta and M. globosa on the healthy 
canine skin, and M. pachydermatis on allergic skin. M. pachydermatis was 8-fold more abundant 
on the skin of laboratory atopic dogs prior to allergen exposure. These findings raised new 
questions regarding the cause of fungal dysbiosis. Some proposed explanations include 
immunologic dysfunction in the allergic individual or alterations to the skin barrier functions 
including hydration and nutrient availability, especially triglycerides and ceramides for 
Malassezia. Future studies with greater numbers of animals, as well as simultaneous 
investigations of immune function, skin morphology, and skin lipidomics might provide insights 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
A brief history on the microbiome revolution  
 Microbiome is defined as the collection of microbes and their gene products that colonize 
a discrete habitat. Microbiota is a term that refers only to the microbial organisms within a 
microbiome, formerly known as microflora.1 The mammalian microbiome can be further divided 
into microbial communities inhabiting anatomically and physiologically distinct body surfaces 
including the oral cavity, respiratory tract, gastrointestinal tract, urogenital tract and skin. The 
main categories of microbes within the mammalian microbiome in decreasing order of 
abundance are bacteria, fungi, viruses and parasites.2  
 One of the major propelling forces of the ‘microbiome revolution’3 was the establishment 
of the Human Microbiome Project (HMP) in 2007.4 This international consortium, partially 
funded by the NIH roadmap initiative, set forth the overarching goals of understanding how the 
human microbiome impacts health, and developing novel therapeutic strategies to control the 
microbiome. The HMP promised to tackle challenges facing the field of microbiome research 
that would enable participation by the broader scientific community. Although the HMP was 
critical in the advancement of microbiome research, they surely were not the first to investigate 
effects of the microbiota on human health.5 Previous researchers though were limited in their 
ability to cultivate host-associated microbes in the laboratory. It has been estimated that 20-60% 
of microbes within the microbiome are not readily cultured.4 This does not come as a surprise to 
the field of microbiology as the ‘great plate count anomaly’ was revealed 35 years ago based on 
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the observation that fewer colonies grew on a plate than the number of bacterial organisms seen 
under a microscope.6  
 Technological advancements were an integral part of this revolution, as was the 
collaboration of scientific disciplines. The advent of massively parallelized DNA sequencing, or 
next-generation sequencing (NGS), in the early 2000’s enabled simultaneous molecular 
characterization of entire microbial communities.7 This was a vast improvement from Sanger 
chain terminated sequencing that required pure culture for sufficient sequence quality to identify 
single microbes in a sample. Microbial phylogenetic markers developed in the 1990s, such as the 
16S ribosomal RNA (16S rRNA) coding region of bacteria and the Internal Transcribed Spacer 
(ITS) region of fungi, were harnessed for targeted amplicon sequencing of bacterial and fungal 
communities. The release of bioinformatics platforms such as QIIME8 and mothur9 provided 
researchers with standardized protocols and software packages to analyze the massive amounts 
of data generated from microbial NGS. One of the early concerns of the HMP was whether 
ecological analyses formerly applied to macro-scale environments would still be accurate for 
micro-scale environments such as the microbiome.10 Ecologists and statisticians were involved in 
the seminal microbiome studies to apply and develop appropriate diversity and community 
distance analyses such as UniFrac.11  
 The anticipated outcome of foundational microbiome studies was a need to correlate 
functional impacts of the microbiome with human health. We quickly saw the birth of new fields 
of ‘omics’ and investigations into the metabolome, proteome and lipidome.12 The ultimate goal 
of microbiome research was the formulation of prebiotics and probiotics that could alter the 
microbiome to remedy disease or promote health in an individual.13 A short decade after the 
HMP was formed, we have already seen the development and testing of various pre- and 
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probiotics.14 The success of microbiome studies in human medicine prompted our investigation 
into the microbiome of our veterinary patients, and the aims presented within this thesis.  
The human skin microbiome in health  
 The healthy human skin microbiome is shaped by a number of biological and 
environmental factors. Pioneers of skin microbiome research began by describing the 
microenvironment of human skin across the entire body, thereby laying a framework for 
interpretation of the presence and distribution of skin microbiota.15 The skin microenvironment 
is largely determined by the anatomy and physiology of skin.  
 Briefly, the skin is comprised of discrete layers with microbes generally colonizing the 
outermost layer, the epidermis, although new research documents the presence of rare bacteria in 
the deeper layer, the dermis.16 The epidermis contains multiple layers of cells at differing stages 
of development with the outermost layer, stratum corneum, being likened to brick and mortar. 
The bricks represent anucleate skin cells, corneocytes, solidified within a mortar of lipid lamellae 
containing ceramides, cholesterol and fatty acids. Other important features of the stratum 
corneum that contribute to the barrier function of skin are keratohyaline granules containing the 
protein Filaggrin, and the envelope surrounding corneocytes made of proteins such as involucrin, 
loricrin, and keratolinin. Scattered throughout the epidermis are appendages including hair 
follicles and glands that extend down into the dermis. Sweat glands are named based on their 
differing secretions and function. Eccrine sweat glands secrete a liquid substance concentrated 
with sodium chloride and function in thermoregulation. Apocrine sweat glands secrete a 
substance rich in steroids that are thought to play a role in pheromone production. Sebaceous 
glands are associated with hair follicles and secrete an oily substance, sebum, containing lipids 
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that function in retaining moisture.15,17 Grice et al. concluded that human skin has a varied 
topography that includes dry, moist and oily microenvironments or niches.15 
 The basic tenets of microbiology require that microbes have a metabolism adapted to the 
nutrient availability of their surroundings and possess adequate defense mechanisms to thrive in 
the face of natural competitors. The skin is much like a desert compared the gastrointestinal tract. 
The surface of the skin is overall acidic, dry and replete of carbohydrate sources.15,17 Some 
examples of major skin commensals adapted to specific skin microenvironments include 
Staphylococcus and Malassezia. Staphylococcus spp. secrete proteases utilizing urea from sweat 
glands as a nitrogen source, and are halotorerant, able to withstand the high concentrations of salt 
in sweat.18 Malassezia spp, that are not able to synthesize their own lipids, secrete lipases 
utilizing triglycerides in sebum as an energy source,19 and phospholipases that allow for invasion 
of host tissue; phospholipases have been shown to vary in virulence dependent upon strain of 
Malassezia.20 Initial studies using NGS to investigate bacterial microbiota of healthy human skin 
demonstrated that certain bacterial taxa were more abundant at specific body sites and that there 
was low inter-individual variability. For example, Propionibacterium that are lipid metabolizing, 
were more abundant in oily or sebaceous areas such as the face and chest, and Staphylococcus 
and Corynebacterium were more abundant on moist skin such as the elbow crease or axillae.21 
 Temporality of the skin microbiome in healthy individuals has also been investigated 
including post-natal colonization, then extending throughout all life stages, and lastly focusing 
on stability within a life stage. The route of initial colonization of the skin in neonates was shown 
to influence the composition of the gut microbiota for up to 7 years of age.22 The skin of babies 
delivered by vaginal route was initially colonized by vaginal microbes such as Lactobacillus or 
Prevotella, and the skin of babies delivered by C-section were colonized by skin microbes such 
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as Staphylococcus and Corynebacterium.23 During the post-natal period commensal microbiota 
educate the immune system in a process called tolerance so that following maturation of the 
immune system, commensals will not induce inflammation, and the body will know how to 
respond to invading pathogens.24 Specifically microbiota can influence the immune system 
through the production of antimicrobial peptides, increasing expression of complement, control 
of the expression of Interleukin 1, and tuning of local T cells.25 It is not yet clear how differences 
in early colonization mechanistically influence the immune system but some studies have shown 
the prevalence of celiac disease, asthma, type 1 diabetes and obesity is greater in children that 
were delivered by C-section compared to the vaginal route.26 
 The skin microbiome during puberty has been extensively studied due to the prevalence 
of acne in pubescent individuals. Studies have shown that pre-pubescent individuals have a 
greater diversity of bacterial microbiota whereas adolescent and post-adolescent individuals have 
a predominance of Propionibacterium and Corynebacterium.18 These alterations have been 
attributed to increasing sex hormones that in turn stimulate an increased production of sebum, 
number of apocrine glands, and density of hair follicles. The result of these physiologic changes 
is increased epidermal lipids thus providing a niche for lipid loving bacteria like 
Propionibacterium and Corynebacterium. However, once reaching adulthood, the skin 
microbiome has been shown to be stable over a two-year span with most of the stability apparent 
at bacterial species and strain levels, and sebaceous areas demonstrating the greatest stability.27  
 A recent review on the geographic variation of the healthy human microbiome 
emphasizes the major challenge in differentiating between genetic, ethnic, environmental and 
cultural factors such as hygiene and diet.28 The authors concluded that mode of subsistence 
(hunter gatherer, rural agriculturalist, western urban industrialized) overshadows ethnic or 
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geographic influences. They found that overall there was a core microbiome and microbial 
diversity was reduced as populations succeeded through stages of subsistence; corresponding 
with decreasing exposure to the environment (soil and natural bodies of water) and changing 
diets. While these effects are more pronounced in the GI microbiota, some studies have found 
the skin to be similarly affected. Hospodsky et al 2014 found increased abundances of 
Propionibacteriaceae, Staphylococcaceae, and Streptococcaceae on the hands of women from the 
US compared to women from Tanzania who had increased abundances of soil associated 
Rhodobacteraceae.29 Even within a focal geographic location, Ting et al 2015 found that urban 
Chinese women had higher abundances of Propionibacterium on the glabella, while rural 
Chinese women had higher abundances of Corynebacterium.30 A factor that is likely more 
pronounced in western civilization is the effect of co-habitation with pets. Cohabitation has been 
shown to be a strong influencing factor in the degree of shared skin microbiota between 
cohabiting individuals.31,32 Cohabitation with dogs was shown to increase the level of shared 
microbiota in cohabiting individuals, with the greatest sharing occurring between the persons’ 
palms and the dogs’ forehead and paws.31 The impact of sharing microbiota between pets and 
cohabiting people is not fully understood. However, studies demonstrating carriage of multi-drug 
resistant bacteria on the skin of healthy pets33-37 reminds us that the effects of cohabitation with 
pets are indeed important to human health.  
The human skin microbiome in disease 
 The perception of microbial pathogenesis has even evolved from a pathogen-centered 
focus, to the damage response framework factoring equal contributions from the host and 
pathogen, and now the effects of entire microbial communities on infectious disease. Koch 
postulated that an individual microorganism could be proven as the etiologic agent of a specific 
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disease. In the early 2000s the damage response framework presented a new way of thinking 
about infectious disease where pathogen virulence is a function of host damage ranging from a 
weakened to hyper-reactive immune system.38 This framework came in a time when the 
prevalence of opportunistic infections in immunosuppressed individuals was on the rise and 
microbes, previously not considered pathogenic, were causing disease in these individuals. 
Colonization resistance was coined in the 1960s to explain how a single bacterium could protect 
from invasion by pathogenic bacteria.39 The microbiome revolution brought into context how the 
entire microbiome collectively acting together could protect against colonization of pathogenic 
bacteria through direct antagonism and enhancement of mucosal immunity.40 Most recently Bird 
and Segre published a letter proposing an adaption to Koch’s postulates that infectious disease 
causation should be interpreted in a systems biology approach including the microbiome.41 We 
now believe that due to the constant interaction between the host and its microbiota, the 
microbiome is involved with many infectious diseases by either preventing or predisposing to 
disease.  
 Dysbiosis, alterations to commensal microbiota, has recently been associated with 
numerous disease processes. The question remains for many of these diseases: which comes 
first? Is the dysbiosis the cause of disease, or does the disease result in dysbiosis?  On almost 
every body surface there is now a correlation of disease with dysbiosis including but not limited 
to: bacterial vaginosis,42 ulcerative colitis,43 periodontal disease,44 and cystic fibrosis.45 Even 
systemic and metabolic disorders such as obesity,46 diabetes mellitus47 and neoplasia48 have now 
been associated with dysbiosis. Diseases affecting skin include acne, chronic wound healing, 
diabetic ulcers, psoriasis, and atopic dermatitis.18 For many of these affecting skin, commensal 
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bacteria become pathogenic, leading one to consider these in a damage response framework with 
contributions from both the host and the entire microbiome.  
 Acne vulgaris is a pustular skin disease affecting pubescent individuals. The bacterium 
isolated from pustules is Propionibacterium acnes. Interestingly P. acnes is found on both 
healthy and diseased skin and is one of the most abundant bacterial microbiota on human skin. P. 
acnes has been shown to induce inflammation within the follicle as well as systemically in 
diseased individuals.49 Disease severity has been associated with increasing sebum activity,18 but 
importantly specific strains of P. acnes have been isolated more frequently from diseased 
individuals.50-53 Further work has shown that these specific strains of P. acnes from diseased 
individuals have differing effects on sebocytes and keratinocytes.54,55 These findings taken 
together suggest that there is strain specific microbial pathogenesis as well as host factors that 
contribute to the disease acne vulgaris. 
 Inflammatory disease has long been suspected of being influenced by microbiota, and 
accumulation of reports that microbiota and the host immune system are highly interactive 
provides further indication. Two inflammatory skin diseases under ongoing investigation are 
psoriasis and atopic dermatitis (AD). Psoriasis is characterized by plaque formation subsequent 
to an initial inflammatory insult. Streptococcal throat infections have been linked to the onset of 
one type of psoriasis, although Streptococcus is a commensal and alone does not induce psoriatic 
lesions in healthy skin.49 Recent microbiome studies have not identified a consistent dysbiosis 
signature associated with  Psoriasis, but they have demonstrated an increased diversity of 
microbiota in lesional skin compared to non-lesional skin. Host genetic mutations affecting 
CD8T cells has been associated with up to 60% of psoriatic patients indicating an immune 
dysregulation is likely involved. Several studies have demonstrated shifts in microbiota 
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following treatment of psoriasis56 leaving researchers to find the link between inflammation and 
dysbiosis in psoriasis.57 
 Dysbiosis has been consistently demonstrated as a significant factor in atopic dermatitis. 
This disease has a prevalence of 15-20% in children worldwide and is characterized by erythema 
and pruritus that progresses to plaque formation.18,49 A portion of these patients then succumbs to 
what is known as the “atopic march,” a progressive series of allergic diseases such as asthma and 
food allergies. This disease is multifactorial with contributions from skin barrier disruption, 
immune dysregulation and dysbiosis. In a subset of patients, a mutation in the gene encoding for 
the stratum corneum protein Filaggrin results in an impaired skin barrier which is thought to 
provide increased exposure to environment.58 The immune dysregulation involves a Th2 
predominated immune response and recruitment of mast cells and allergen specific IgE to the 
skin.  Staphylococcus aureus carriage is reported at 30-100% in atopic individuals.58 Founding 
NGS studies of AD demonstrated a correlation between atopic flares and increasing relative 
abundance of S. aureus.18 This bacterium has been shown to induce further inflammation and 
damage to the skin barrier thereby exacerbating lesion severity.49 Recently Nakatsuji et al. has 
shown that atopic skin is lacking colonization of coagulase negative Staphylococci (CoNS), such 
as S. epidermidis and S. hominis. CoNS have been shown to produce antimicrobials that keep S. 
aureus abundances in check. Lack of CoNS on infant skin has also been shown to increase the 
risk of developing AD later in life. Researchers conclude that exposure to CoNS may be 
preventative for the development of AD and future therapeutics may be developed targeting the 





The fungal microbiome and its unique challenges 
 The fungal microbiome and its effects on human health have been studied far less than 
the bacterial microbiome. This is in part due to the presence of fewer fungal genomes in the 
human microbiome thus posing a challenge for adequate sequencing depth. A recent review 
documents that up to 10% of samples in a fungal microbiome study can be expected to be lost 
due to low number of sequences.59 Although the genomic copy number of fungi is lower than 
that of bacteria, the size of fungal organisms tend to be 100 times greater than bacteria.60,61 
Theoretically the surface area covered by fungi is greater than bacteria, and the overall microbial 
biomass should be greater. This leads one to question whether the impact of fungal metabolites 
on the host could be greater too. The few number of fungal genomes is further compounded by 
the fact that skin has a lower overall microbial biomass compared to other human microbiomes 
such as the gastrointestinal tract.  
 Aside from genomic copy number, other unique challenges of studying the fungal 
microbiome are nuances of the ITS region, incomplete databases, and the lack of standardized 
protocols. Large-scale bioinformatics studies have shown that the ITS region is ideal for 
barcoding due to its high level of sequence variability between genera.62 However, this sequence 
variability prevents it from being used to calculate a kingdom wide phylogenetic reference tree.59 
Many of the OTU picking algorithms and diversity analyses, such as UniFrac,11 designed for the 
study of bacteria cannot be used for fungi due to the lack of a consensus tree. This has likely 
contributed to the lack of standardized bioinformatics protocols available. Additionally, fungi 
tend to be fastidious growers in the laboratory leaving our fungal databases incomplete. Many 
fungal microbiome studies are left with numerous sequences that cannot be classified, potentially 
missing biologically important associations between uncultivated taxa and health or disease. 
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Another complication of many available databases is the inclusion of both anamorph and 
teleomorph names for the same organism, which can lead to inaccurate interpretations of 
biological significance and over or under representation of specific taxa.  
 Skin was the first part of the human mycobiome to be described.63 In contrast to the 
bacterial microbiome of skin, the mycobiome was predominated by only one genus, Malassezia, 
except at the feet that have a higher diversity, comprised of environmental fungi. These findings 
correlated well with previous cultured-dependent studies of skin. Temporal studies of the skin 
mycobiome found that core body sites remained stable and represented a greater portion of the 
metagenome than did mycobiota of the feet that were low in abundance and exhibited high 
variability.27 Although Malassezia is the predominant fungal commensal in adults, children 
possess a much greater diversity of mycobiota with increased abundances of Euritiomycetes 
(which includes the fungi responsible for causing dermatophyte infections).64 This finding was 
interesting given the prevalence of pediatric dermatophytosis. It is thought that just as increasing 
epidermal lipids during puberty promote the growth of Propionibacterium, so it does for 
Malassezia. Just recently in 2017 Petrosino et al. described the gastrointestinal mycobiome of 
the HMP cohort and found Malassezia, Candida and Saccharomyces to be the most abundant 
commenals.65 This group also found there was a high degree of intra and inter-individual 
variability. In the last couple of years high quality reviews have been published on the 
methodology of mycobiome studies and so we hope more studies investigating its role in health 
and disease will be conducted in the near future.59,61,66  
  Similar to bacteria, fungi have recently been shown to modulate the immune system.67 
Fungi interact with the immune system through mannans present in their cell walls with toll-like 
receptors and c-type lectins. On the skin, Malassezia secrete metabolites such as indole that bind 
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to aryl hydrocarbon receptors and function in epithelial repair, melanogenesis, and barrier 
homeostasis. Additionally, Malassezia metabolize triglycerides in sebum into short chain fatty 
acids that have been shown to have a number of immunomodulatory effects. Interactions of fungi 
with the immune system continue to be an area of investigation especially with increasing 
evidence of the association of fungal dysbiosis with disease. 
 To date fungal dysbiosis has been associated with disorders of the immune system, 
delayed epithelial repair and inflammatory skin disease, although these studies are present in low 
numbers and caution should be taken in deriving strong conclusions. Patients with primary 
immune deficiencies possess varying genetic mutations resulting in impaired immunity but all 
experience atopic-like eczema. These patients were found to have increased fungal diversity 
comprised of fungi that commonly cause chronic opportunistic infections in these patients 
including Candida and Aspergillus.68 Delayed wound healing has been associated with increased 
abundances of pathogenic or allergenic fungi in the mycobiome of diabetic foot ulcers.64,69 This 
study identified the mycobiota as a prevalent component of the DFU metagenome, and that 
fungal diversity increased following antibiotic administration. The authors concluded that 
antibiotic administration could be contributing to the prolongation of healing by increased fungal 
colonization of wounds. One study has been performed investigating the mycobiota in 
Psoriasis.70 This studied identified an increased fungal diversity on the skin of psoriatic patients 
compared to healthy controls with an overall reduction in Malassezia. Similar findings have been 
reported for atopic dermatitis, along with changes to the species distribution of the genus 
Malassezia. M. slooffieae and M. dermatis were found to be increased on atopic skin compared 
to healthy controls.71  Interestingly in all four diseases discussed here, increased fungal diversity 
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and decreased abundances of the main fungal commensal Malassezia, have been associated with 
various disease states.  
A note on terminology regarding inflammatory skin disease in companion animals 
 The terms ‘allergy’ and ‘allergic’ will be used throughout this thesis to describe 
inflammatory skin disease and the animals diagnosed with these conditions. “Atopic dermatitis’ 
is a term in veterinary medicine that is reserved for dogs who have a hypersensitivity to 
specifically environmental allergens and thus some of the disease factors are similar to AD in 
people. However, dogs can also have hypersensitivities to proteins in their food, most commonly 
to beef and chicken, or to flea saliva. Regardless of the inciting allergen these dogs, collectively 
referred to as ‘allergic,’ are at increased risk of developing secondary infections including 
Staphylococcus pyoderma and Malassezia dermatitis. Due to this reason, the assumption has 
been made that underlying pathologies that are likely similar, and thus we have included them 
within the same study group. Another reason is that allergic dogs will sometimes have 
hypersensitivity to more than one allergen (food, flea and environment), preventing stratification 
of these patients into separate study groups. Future studies may investigate disease factors and 
the microbiota separately based on inciting allergen, but was not the purpose of our work.  
 Cats are not known to possess the same similarities of their hypersensitivity dermatitis 
with atopic people. However, they can be hypersensitive to the same inciting allergens as dogs 
including food, fleas and the environment. As such the terminology reserved for their 
hypersensitivity dermatitidies are again different and include: flea-bite, food-induced, and non-





Inflammatory skin disease in companion animals 
 Much of what we know about the role of microbiota in inflammatory skin disease comes 
from studies of AD in people. Contextual interpretation of the microbiota in inflammatory skin 
disease of animals must consider important differences in skin anatomy, physiology and disease 
presentation. Dogs and cats are covered with pelage of differing thickness, hair quality, and 
length which can affect the temperature and moisture of the skin surface.17 This tends to vary 
most significantly by breed of dog, however in-breeding has likely also resulted in the 
accumulation of additional genetic mutations that could contribute to the skin microenvironment. 
The potential role of breed heritable effects on the skin microenvironment has not been 
investigated in depth. Gland distribution is also different in dogs and cats. Eccrine sweat glands 
tend be concentrated on the foot pads, whereas apocrine glands are more evenly distributed 
across the body.17 Aside from anatomical differences, the composition of gland secretions and 
lipid content of lamellae in animals is not fully understood. Although general functions of glands 
are likely to be similar, differences in proportions of proteins and lipids could have a profound 
effect on the microbiota. Further investigation is warranted to appreciate the distribution of skin 
microbiota in animals.  
 Inflammation in the skin of animals and people causes similar clinical signs such as 
erythema and pruritus, however, subsequent lesion development differs. Instead of dry 
eczematous plaques such as is observed in atopic people, allergic dogs develop lesions associated 
with secondary skin infections- most commonly Staphylococcus pyoderma, and Malassezia 
dermatitis and otitis.17 Staphylococcus pyoderma is characterized by superficial dermatitis or a 
pustular folliculitis, and Malassezia dermatitis is characterized by grease, scale, crust and 
occasional pustules. These infections have been shown to contribute to pruritus and commonly 
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are recurrent throughout an atopic dog’s lifetime. Chronic Malassezia dermatitis causes 
lichenification and hyperpigmentation of skin, although chronic inflammation of the skin may 
also present in an identical manner. In addition to classical atopic dermatitis, dogs may also 
present with similar skin lesions in response to food allergies, known as cutaneous adverse food 
reaction. The distribution of these lesions in dogs, regardless of inciting allergen, occurs 
predominantly on the face, ears, feet, folds such as the axilla and inguinal region, and flexure 
surfaces. Importantly, this lesion distribution is identical to that of atopic people making dogs an 
appropriate model to study AD.  
 Allergic skin disease in cats is characterized by markedly different lesion presentation 
with four main patterns: cervicofacial dermatitis, eosinophillic skin disease complex, milliary 
dermatitis and self-induced alopecia.72  The eosinophillic skin disease complex is a rather unique 
disease presentation in cats and can include the presence of indolent ulcers of the upper lip, 
eosinophilic plaques of the abdomen and medial thighs, and eosinophillic granulomas of the oral 
cavity, chin or caudal thighs. Unlike allergic dogs that are highly predisposed to secondary 
infections these are relatively uncommon in cats, but when they do occur are predominantly 
Staphylococcus pyoderma, and Malassezia dermatitis or otitis.  
 The underlying pathogenesis of atopy in dogs shares both similarities and differences 
with the same condition in people.73 A subset of dogs was identified as having a mutation in 
filaggrin shown to contribute to skin barrier impairment in canine atopic dermatitis. Also similar 
to people, studies have shown that atopic dogs have transepidermal water loss, ceramide 
abnormalities, and increased levels of IgE in the skin against environmental allergens. Members 
of the taskforce on canine atopic dermatitis caution that cAD is a clinical syndrome and not all 
patients will exhibit this exact combination of abnormalities.74 Onset in companion animals tends 
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to occur early in life around 1 to 3 years old.75 An interesting thought that has yet been 
unexplored, possibly due to the lack of comparative mammalian studies, is that atopic dermatitis 
in people is generally a disease of children, whereas atopic dermatitis in companion animals is a 
lifelong condition. People undergo significant changes in their skin lipid content during puberty 
causing a shift in their skin microbiota. To our knowledge, this phenomenon does not occur in 
most of our companion animals, possibly because they are spayed and neutered at a young age.  
Future studies comparing the prevalence of atopy or composition of epidermal lipids in intact 
animals compared to spayed or neutered animals may help answer this question. 
The microbiome in companion animals   
 Exponentially less is known about the skin microbiota of animals and whether dysbiosis 
is associated with disease in dogs and cats. The first canine microbiome to be described was in 
the gastrointestinal tract. Major bacterial phyla in the canine gastrointestinal tract are similar to 
those in people. Shifts in the gastrointestinal microbiota were documented in both acute and 
chronic diarrhea in dogs, most notably a loss of commensal bacteria and increased abundances of 
Clostridium perfringes.76,77 Dysbiosis in canine inflammatory bowel disease differs with 
increased abundances of Proteobacteria such as Enterobacteriaceae and decreased abundances of 
Firmicutes such as Clostridia.78 Based on these findings, the administration of probiotics has 
become more common in the treatment of diarrhea and inflammatory bowel disease in veterinary 
medicine. While some studies have shown beneficial outcomes of probiotic administration in 
diarrhea and IBD, a recent exhaustive review cautions these effects may be strain dependent and 
the results are not consistent.79 
 Prior to the initiation of  this thesis work, the skin microbiota of dogs and cats had not 
been investigated using NGS with the exception of one publication in 2014 describing the 
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bacterial microbiota of healthy and allergic dogs.80 This study looked at a variety of factors 
including breed, age, sex, presence of fleas, housing habitat, and indoor and outdoor 
environments. Compared to human skin, the skin of dogs had more Proteobacteria and it was 
hypothesized this could be due to increased environmental exposure. In support of this 
hypothesis, a recent study of the skin microbiome across all mammals found that the human skin 
microbiome was distinct from all other mammals.81 Non-human mammals in this study had 
greater abundances of soil-associated bacteria. Ross et al. concluded that hygiene and 
environmental exposure were likely influencing the differences observed in humans and non-
human mammals.  
 More recently several studies have investigated breed, environmental factors, and 
temporality affecting the healthy skin microbiota of dogs.82,83 Sampling of the skin microbiota in 
cohabiting dogs over time demonstrated a significant influence of cohabitation.82 This study also 
concluded that season was an influencing factor, however, for this to be true, the authors should 
have sampled the dogs over multiple years. The study design that only sampled dogs over the 
course of one year, only allows for correlation of microbiota with temporality and not season. 
Another study controlled for breed and environment influences by only sampling dogs from a 
related background that shared the same environment.83 This group found that the individual 
followed by body site were the main driving factors. These studies taken together suggest that 
breed, environment, cohabitation, and seasonality may all be important variables to control for in 
the study design of skin microbiome studies of animals. 
 Following the undertaking of this thesis work, the skin of allergic dogs has been more 
extensively studied. As of now the skin microbiome in allergic dogs has been evaluated in 
longitudinal studies of atopic flares, and after the administration of immunomodulatory drug or 
 
 18 
antimicrobials. Bradley et al. sampled atopic dogs at lesion flare, 4 weeks after starting antibiotic 
administration, and 4-6 weeks following cessation of antibiotics.84 They found Staphylococcus 
pseudintermedius predominated atopic dogs during flares, and abundance of S. pseudintermedius 
correlated with lesions severity. Abundance of S. pseudintermedius and lesion severity was 
significantly reduced following antibiotic administration. However, the authors caution that with 
the rise of antibiotic resistance alternative approaches for controlling S. pseudintermedius in dogs 
should be investigated.  A similar study by Pierezan et al. investigating the skin microbiota in an 
inducible canine model of atopic dermatitis demonstrated increased abundances of 
Staphylococcus following exposure to allergen using both NGS and real-time quantitative PCR.85  
 Immunomodulatory drugs such as glucocorticoids and cyclosporine are commonly 
prescribed treatments for atopic dermatitis in dogs. Widmer et al. tested the effects of these drugs 
on the skin microbiota of atopic dogs who were not experiencing flares or infections.86 They 
concluded that these drugs did not have any effect on the bacterial diversity or community 
structure. Despite their conclusions, some trends indicated the opposite, and the small sample 
size possibly influenced lack of significance in this study, since only 6 dogs were included.   
Another group tested the effect of topical antimicrobial shampoo with both antibacterial and 
antifungal spectrum on healthy and atopic dogs.87 This study demonstrated significant changes to 
the bacterial and fungal community composition following treatment. The overall bacterial 
diversity increased and fungal diversity decreased with treatment. One limitation to this study 
was a small sample size of only 9 dogs, and future larger studies are warranted to determine the 
effects of topical antimicrobials used to treat atopy in dogs. It remains difficult to interpret the 
impact of changes to microbiome structure following treatment, but could serve as tool to 




 Prior to the this thesis work the skin mycobiome of companion animals had not been 
described using NGS,  and the role of the mycobiome in canine atopic dermatitis and feline 
hypersensitivity dermatitis was unknown. Atopic dogs are at a higher risk of developing 
secondary Malassezia dermatitis and otitis compared to healthy dogs, and recent works have 
demonstrated inter-microbial interactions that could influence host health. This lead us to the 
aims of this thesis project which were to describe the skin mycobiota of dogs and cats, and then 
to investigate how the skin mycobiota may be altered in allergic animals. Due to Malassezia 
pachydermatis being a common opportunistic pathogen in allergic dogs, we also aimed to derive 
species level abundances of Malassezia in healthy and allergic dogs. Lastly we aimed to 
determine whether shifts in the abundance of Malassezia species occur as a result of allergen 




CHAPTER II 1 
CANINE CUTANEOUS MYCOBIOTA 
Introduction 
 Skin diseases are often characterized by multifaceted etiology with potential 
contributions coming from the host’s genetics, skin barrier integrity, immune system, and 
inflammatory components, which can be exacerbated by environmental exposure and hygiene 
practices.88 The cutaneous microbiota associated with skin diseases have only recently been 
investigated in humans. Through this work, dysbiosis (an alteration to the normal microbiota) of 
cutaneous microbiota has been associated with a variety of human skin diseases including 
psoriasis (PS),70,89 acne vulgaris,90 and atopic dermatitis (AD).68,91 Fewer studies have focused 
on how the microbiota influences skin health of other host species such as dogs.80 In addition to 
improving animal health, these studies are needed to evaluate how animal behavior, anatomy, or 
environmental exposure affects cutaneous microbiota, and ultimately health status of the host. 
Interest in the microbial communities of companion animals is growing as we begin to recognize 
how their microbiota can influence our own31 and possibly affect human health for people 
cohabiting with pets.92  
Atopic dermatitis (AD) is a pruritic condition characterized by a skin barrier dysfunction 
and hyper-sensitization to environmental allergens.93,94 In both people and dogs, there are 
increased levels of IgE to environmental allergens, an initial Type I hypersensitivity reaction 
characterized by increased numbers of  T-helper type-2 (Th2) cells in lesional skin, and later 
Type IV hypersensitivity in chronic cases, supporting a similar pathogenesis of AD in these two 
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host species.94 Fungi are generally thought to be less influential in the pathogenesis of AD, 
however Malassezia hypersensitivity has been implicated in both human and canine AD through 
patch testing, IgE studies, and responsiveness to antifungal therapy.95-100 Recently, next 
generation sequencing (NGS) studies have identified bacterial dysbiosis associated with affected 
human skin in AD91 and PS,89 and with non-affected skin in dogs with allergic skin disease, 
which includes AD.80 Bacterial dysbiosis associated with AD and PS is characterized by a 
reduction of bacterial diversity in affected skin, and shifts in relative abundance of particular 
bacterial species.89,91 Fungal dysbiosis has also been reported for these diseases in humans, but 
instead of reduced diversity as found for the bacterial microbiota, there is an increase in fungal 
diversity at the site of lesions,68,70,101 and clustering by health status in principle coordinates 
analysis.68,70,101 
Prior to investigating how a disease process has altered the host microbiota, or if the 
microbiota might play a role in disease pathogenesis, there must be the initial studies of healthy 
skin microbiota and determination of the factors influencing their ecological distribution and 
function. A few studies have characterized the fungal microbiota (mycobiota) of human skin 
using NGS.63,68,70,101-103 One study revealed that healthy human skin is predominantly colonized 
by the genus Malassezia with body site differences seen only for the different species of 
Malassezia.63 Fungal diversity was dependent upon body site, and the greatest diversity was 
found in samples from feet. Retesting of individuals over time demonstrated a stable fungal 
community structure at the core and arm body sites, but not at the feet. Overall fungal 
community structure was strongly correlated with the site location (head, torso, arms, feet),63 in 




We are still in the early stages of describing the skin microbiota in companion animals 
using NGS. To date there has been one NGS study published by our group characterizing the 
bacterial microbiota of canine skin.80 Similar to human skin, bacterial community composition is 
significantly different between body sites. The predominant phylum across all body sites in dogs 
is Proteobacteria, unlike human skin that is predominantly colonized by Actinobacteria and 
Firmicutes.21 Richness and diversity of bacterial taxa varies across the canine body sites with the 
nostril and conjunctiva harboring the fewest, and the dorsal nose the greatest.80  
 Descriptions of the mycobiota in dogs using NGS has been limited to the fecal mycobiota 
in healthy dogs and those with diarrhea.104 The only studies aimed at characterizing fungi on the 
skin of dogs have been culture-based.105-111 One study sampled strictly the ears of dogs (n=194), 
that were either healthy, atopic or had otitis.110 In this study, the most abundant fungal organism 
cultured was Penicillium spp., and the second was Malassezia pachydermatis. Another study 
from France cultured fungi from the conjunctiva and adjacent skin on the nose of dogs and 
identified the presence of additional fungi including Alternaria, Cladosporium, and 
Aspergillus.111 While these studies are all valuable, it is well documented that molecular-based 
studies provide a more comprehensive picture of the microbial landscape due to the non-
cultivable nature of some microbes or “selective” culture of others.112   
 The goal of this study was to characterize the canine cutaneous mycobiota using NGS, 
and determine whether body sites influenced the distribution of fungal organisms. Ten distinct 
body sites, consisting of haired skin, mucosal surfaces and one mucocutaneous junction were 
sampled in ten healthy dogs. We expected to find a greater diversity of fungal commensals than 
what has been detected by fungal culture alone. Similar to human skin, we expected to see a 
dependence of fungal communities on site location. To additionally investigate the role of the 
 
 23 
mycobiota in canine allergic skin disease, we also collected skin swabs from eight dogs with 
clinical allergic skin disease at six body sites that are commonly affected by cutaneous 
manifestation of allergies. We expected to find changes in the diversity, membership and 
structure of fungal communities, as well as increased abundances of Malassezia pachydermatis 
owing to its implication in canine AD. 
Materials and Methods 
Subject Recruitment 
 All samples for this study were collected following a protocol approved by the Texas 
A&M University Institutional Animal Care and Use Committee. Ten dogs (D1-D10) with no 
history of skin disease were recruited for collection of healthy skin samples (Table 1). These 
dogs ranged from 1.5 to 11 years old, and included five castrated males and five spayed females. 
There were four mixed breed dogs, two Jack Russell Terriers, one Beagle, one Pitbull, one 
Boston Terrier, and one German Shepherd. A board certified veterinary dermatologist clinically 
evaluated the ten healthy dogs, and also evaluated eight additional dogs (D11-D18) for inclusion 
in the allergic group (Table 1). Six dogs were diagnosed with AD using standard diagnostic 
methods including fulfillment of Favrot's criteria and exclusion of other pruritic dermatoses.113 
One dog was diagnosed with chronic pododermatitis and cutaneous adverse food reactions 
(CAFR), and one dog was diagnosed with only CAFR. The allergic dogs ranged from 2 to 10 
years old, included four castrated males, and four spayed females. The breeds of allergic dogs 
were two Boston Terriers, two Cavalier King Charles Spaniels, one Shetland Sheepdog, one 
Australian Shepherd, one Labrador retriever, and one mixed breed dog. To be included in the 
study, dogs could not have displayed overt clinical signs of bacterial or fungal skin infections at 
the time of sample collection. Five out of the eight allergic dogs were receiving medication for 
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their AD: oral immunotherapy (2), oclacitinib (Apoquel®, Zoetis) (2), and oral cyclosporine 
(Atopica, Novartis) (1). All healthy study participants did not receive systemic antibiotics or 
antifungals six months prior to collection of samples, and allergic study participants one month 
prior. Additionally, no dog was allowed to be bathed one week prior to the beginning of the 
study. Healthy dogs had not received steroids previously, and all but one of the allergic dogs had 
not received steroids within the last month prior to the study. Allergic dogs were allowed to have 
their allergic disease managed with either long-term medication and/or immunotherapy without 
the need for withdrawal for study inclusion purposes. None of the allergic dogs were 
experiencing lesions or flares at the time of sample collection. 
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Table 1. Medical histories and environmental exposures of dogs enrolled in this study. Allergy pruritus, ear problems and fleas were 
part of the clinical history and not clinically present at the time of sample collection.  
Dog Health 
Status 















D1 Healthy Jac 9 M N N N 80 TGW CTFB N/A N Y 
D2 Healthy Mix 1.5 M N N N 90 GW CTFB N/A N N 
D3 Healthy Mix 2 M N N N 80 TGW CTFB N/A N N 
D4 Healthy Mix 3.5 M N N N 90 TGW CTFB N/A N N 
D5 Healthy Bea 2 M N N N 90 GW CTFB N/A N N 
D6 Healthy Mix 1.5 F N N N 70 TGW CTFB N/A N N 
D7 Healthy Pit 9 F N N Y 90 TGW TF N/A N N 
D8 Healthy Bos 3 F N N Y 70 TGW TF N/A N N 
D9 Healthy Jac 11 F N N Y 90 TGW CTFB N/A N N 
D10 Healthy Ger 7 F N N N 50 TGW CTFB N/A N N 
D11 









D13 Allergic Mix 6 M Y Y N 70 TGW TFB Apoquel Prednisone Y 
D14 Allergic Cav 2 F Y N Y 99 TGW CTFB Y Y 
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Table 1. Continued 
Dog Health 
Status 















D15 Allergic She 5 F N Y N 95 TGW CTFB Cyclosporine N N 
D16 Allergic Aus 3 M N N N 50 TGW CTFB Prednisone N 
D17 Allergic Lab 10 F Y N Y 95 TGW T Fluconazole Prednisone N 
D18 Allergic Cav 10 F Y Y Y 90 TGW TF Apoquel N N 
Jac: Jack Russell Terrier, Mix: Mixed breed, Bea: Beagle, Pit: Pitbull Terrier, Bos: Boston Terrier, Ger: German Shephard,  Cav: Cavalier King Charles Spaniel, 
She: Shetland Sheepdog, Aus: Aussie, Lab: Labrador, T: Trees, G: Grass, W: Weeds, C: Carpet, T: Tile Floors, F: Furniture, B: Bedding. Allergy treatments 
were concurrent, and D16 was the only dog currently taking steroids, all others with a Y had not received steroids in the last month (Meason-Smith, 2015). 
 
 27 
Sample Collection and DNA Extraction 
 Ten body sites on healthy dogs were swabbed including the axilla, conjunctiva, dorsal 
nose, ear canal, groin, interdigital space, lip commissure, lumbar, nostril, and pinna.  Six body 
sites on allergic dogs that are commonly affected by cutaneous manifestation of allergies were 
swabbed including the axilla, ear canal, groin, interdigital space, lumbar, and nostril.  Samples 
were only collected from the right side of all dogs. Gloves were changed between dogs and the 
exam table was wiped down with DNA away (Molecular BioProducts, Inc., San Diego, CA) 
after each dog was sampled. Three superficial skin swabs (Isohelix,Cell Projects Ltd. UK) were 
used for each body site, with swabs being rubbed ten times on each side of the swab within an 
area of approximately one square inch. Two swabs were immediately stored in lysis buffer from 
the MoBio Power Soil DNA Extraction kit (MoBio Laboratories, Inc., CA) to be extracted and 
sent for sequencing, and the third was retained in a sterile tube for archiving purposes. All swabs 
were stored at 4°C for no more than one week before extraction and final storage at -80°C. DNA 
was isolated using the MoBio Power Soil DNA Extraction kit, following the manufacturer’s 
protocol. Negative controls were also included in sequencing: including sterile swabs that were 
processed following the extraction protocol, and the reagents only, with no swab included.  
 For comparison of sequences between our extraction protocol and the protocol followed 
by Findley et. al.  2013, we collected four swabs from the right ear of five healthy dogs taking 
the same precautions as above. Two swabs were used following the above DNA extraction 
protocol and two followed the Findley protocol.  
ITS Sequencing and Sequence Analysis 
 Extracted DNA was submitted to MR DNA Laboratory (Shallowater, TX) for Illumina 
sequencing on a MiSeq Instrument using ITS1F (5'-CTTGGTCATTTAGAGGAAGTAA-3') and 
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ITS4R (5'-TCCTCCGCTTATTGATATGC-3') primers. Resultant sequences from the forward 
reads were processed in Mothur,9 an open-source bioinformatics software. First, sequences were 
trimmed for quality, sequences less than 200 bases were culled out and the remaining were 
chopped at 250 bases. Next, chimeras were removed with Uchime,114 and OTUs were binned by 
taxonomic classification (phylotype) with the ITS-1 Findley et. al.  2013 database following their 
recommended parameters. Alpha diversities including inverse Simpson, non-parametric 
Shannon, Chao1, and observed species were calculated with a rarefaction depth of 1900 
sequences. To assess both the membership and structure of fungal communities, distance 
matrices for healthy samples, allergic samples, and shared sites were generated using Bray-Curtis 
(membership), Jaccard (membership) and Yue-Clayton theta coefficient metrics (structure), with 
a rarefaction to 1900 sequences. These distance matrices were formatted for use within QIIME to 
generate principle coordinates of analysis (PCoA) plots.  
Statistical Analysis 
 Alpha diversity estimators and relative abundances were first confirmed non-normal with 
the Shapiro-Wilk test in the statistical software JMP Pro 11 (SAS Institute, Inc.). A significance 
value of P<0.05 was selected for all statistical tests. A Kruskal-Wallis test was performed to 
determine if the alpha diversity of at least one body site or dog was significantly different from 
the others. When significance was identified, a Steel-Dwass All Pairs test was performed to 
identify the body sites or dogs that were significantly increased or decreased (JMP). A Mann-
Whitney test was performed for each shared body site (a body site that was sampled in both 
healthy and allergic dogs; n=6), to determine whether the samples for one health status were 
significantly different from the other (JMP). Analysis of similarities (ANOSIM) function in the 
statistical software package PRIMER 6 (PRIMER-E Ltd., Luton, UK) was performed on 
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Mothur-generated distance matrices (Bray-Curtis, Jaccard, and Yue-Clayton theta coefficient) to 
determine the influence of various factors (body site, individual dog, health status) on the 
dissimilarity between mycobiota of the groups being examined. The relative abundance tables 
generated in Mothur for each taxonomic level were combined and filtered to only include taxa 
that were present in at least 20 samples at greater than or equal to 0.1%. To identify taxa whose 
relative abundance was significantly different between body sites, individual dogs or health 
statuses, the filtered relative abundance table was imported into JMP and Kruskal-Wallis tests 
were performed. The filtered relative abundance table was also formatted for linear discriminant 
analysis (LDA) effect size (LEfSe)115 to identify significant differences in taxa between health 
statuses. All p-values were corrected for multiple comparisons using the Benjamini & Hochberg 
False discovery rate.116  
 Raw sequences were uploaded to the NCBI Sequence Read Archive under the project 
number: PRJNA293511. 
Results 
 From the 148 canine body sites sampled, four were removed from analysis due to low 
number of sequences. The total number of fungal sequences amplified from the remaining 144 
samples totaled 4 477 229 after quality processing and chimera removal; the median number of 
sequences per sample was 30 354.  
Fungal Diversity Analyses of Healthy Canine Skin 
 Two factors were considered in the diversity analyses of healthy dogs: the influence of 
body site and of the dog. To test the effect of body sites, the same sites from all dogs were 
analyzed as a group. Conversely, to test the effect of the dog, all body sites from the same dog 
were analyzed as a group.  Next, the diversity estimators for each group were compared. If there 
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were significant differences between the groups, we concluded that factor had an influence on 
the diversity of the cutaneous mycobiota. We found an overall significant effect of body site on 
the richness (observed species, P=0.0002; Supplementary Table S1) and diversity (Shannon, 
P=0.028; Supplementary Table S1) of the cutaneous mycobiota. The mucosal surfaces, nostril 
and conjunctiva, accounted for most of this difference and had a significantly reduced number of 
observed species compared to all other sites (P<0.05; Fig.1a). However, when taking into 
account evenness with the Shannon metric, we found that only the nostril was significantly less 
diverse (P<0.05; Fig. 1b) than all other sites. We also found a significant effect of the individual 
dog on the richness (observed species P<0.0001; Supplementary Table S1) and diversity 
(Shannon P=0.0003; Supplementary Table S1) of mycobiota. The mycobiota of dog number 10 
was more rich (P<0.05; Fig. 1c) and diverse (P<0.05; Fig. 1d) than that of all other dogs. Median 





Figure 1. Alpha diversity of healthy dogs. Asterisks denote body sites or dogs that are 
significantly different from all other sites or other dogs (Kruskal-Wallis, multiple comparisons 
test, P<0.05). (a) Species richness estimator was calculated with observed species and samples 
were grouped by body site. (b) Diversity estimator was calculated with Shannon, and samples 
were grouped by body site. (c) Species richness estimator was calculated with observed species 
and samples were grouped by dog. (d) Diversity estimator was calculated with Shannon, and 




 The same two factors were examined to determine their influence on the membership and 
structure of fungal communities (beta-diversity) residing on healthy canine skin. To answer this 
question, ANOSIM was performed on rarefied distance matrices (membership: Bray Curtis and 
Jaccard metrics; structure: Yue-Clayton coefficient). To determine the effect of one factor on the 
membership or structure, pairwise comparisons were made between all body sites or between all 
dogs. An R value and p-value were produced for each comparison, and an R value closer to zero 
indicated similarity between the pair, whereas an R value closer to one indicated dissimilarity 
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between the pair. When examining a factor, higher R values indicated that factor has an 
influence on the beta-diversity.   
 We found that the individual dog factor had a greater influence (median R values=0.338, 
0.535, 0.381 respectively; Supplementary Table S4) on the beta-diversity of cutaneous 
mycobiota than did the body site factor, which was not a significant influencing factor for any of 
the 45 pairwise comparisons made between healthy body sites (Fig.  2a). From the 45 
comparisons between healthy dogs, 38 pairs were significantly dissimilar (P<0.05; 
Supplementary Table S4). These findings were visualized with principal coordinates of analysis 
(PCoA) plots generated from rarefied Bray-Curtis distance matrices, which showed no sample 
clustering by skin microenvironment (Fig.  2b), or body site (Fig.  2c), but showed clustering of 
all body sites for several dogs (Fig.  2d). However, not every dog demonstrated tight clustering 









Figure 2. The influence of skin microenvironment, body site, and dog on fungal community 
membership. (a) The overall sample statistic (R) from the global test for the two factors 'Body 
Site' and 'Dog' were calculated in Primer6 with ANOSIM on the distance matrix containing only 
healthy or only allergic dogs. Pairwise distance calculations were performed in Mothur using the 
following metrics: Bray Curtis (blue), Jaccard (red), and the Yue-Clayton theta coefficient 
(green).  The R-values for each test are plotted as bars and grouped by factor tested (top), and 
health status of samples included (bottom). (b) PCoA plot was generated in QIIME with samples 
colored by skin microenvironment, and pairwise distance calculations were performed in Mothur 
using the Bray-Curtis metric. (c) PCoA plot was generated in QIIME with samples colored by 
body site, and pairwise distance calculations were performed in Mothur using the Bray-Curtis 
metric. (d) PCoA plot was generated in QIIME with samples colored by dog, and pairwise 





Fungal Community Composition of Healthy Canine Skin 
 In addition to diversity analyses, the taxonomic composition of the mycobiota was also 
determined. The predominant phylum of fungal organisms sequenced from healthy canine skin 
was Ascomycota followed by Basidiomycota. The major class of Ascomycetes was 
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Dothideomycetes and the most abundant genera within this class included Alternaria, 
Cladosporium, and Epicoccum. The most abundant Basidiomycete genera included 
Cryptococcus and Malassezia. There were also other Ascomycete taxa that were abundant but 





Figure 3. Average relative abundance of fungal taxa by body site in healthy dogs. The average 
relative abundance of predominant taxa was calculated for each body site and represented by pie 




 To determine whether the relative abundance of specific fungal taxa differed between 
body sites or individual dogs, statistical analysis was performed on the relative abundance tables 
generated from Mothur. The relative abundance table, including all taxonomic levels, was 
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filtered to only include taxa that were present in at least 20 samples at greater than 0.1%. Using 
this filtered table that included 193 taxa, we identified four fungal taxa that were significantly 
different between body sites in healthy dogs, and 153 that were significantly different between 
dogs (P<0.05; Supplementary Table S5). The LEfSe analysis did not reveal any taxa that were 
significantly different between body sites. These findings are further visualized by stacked bar 
plots of the relative abundances of fungal taxa for each sample, which showed a high degree of 
variation between dogs (columns) for the same body site (rows) (Figs. 4a and 4b). Similar to the 
diversity analysis, the individual dog factor had a greater influence on community composition 
than did the body site factor, indicating that specific taxa were found across all body sites in one 
dog, but not present on other dogs.  
 
 
Figure 4. Fungal taxa summary plots for healthy and allergic canine skin. Stacked bar plots 
represent the predominant fungal taxa present within a sample. (a) Body Sites are arranged in 
rows with each column representing the body site of one dog (numbered at the bottom). (b) 
Shared sites between healthy and allergic dogs are arranged with healthy on the left and allergic 
on the right in a similar orientation as (a). (c) The relative abundance of predominant fungal taxa 
was averaged across all dogs in each health status group for each body site. H represents healthy 




 To test if the extraction protocol used in this study had an effect on the ability to extract 
Malassezia DNA, we compared this extraction protocol to that of Findley et. al. 2013. 
Comparison of the two extraction protocols yielded no significant differences in the relative 
abundance of Malassezia detected in the ears of five dogs (Supplementary Fig.  S1a), and both 
protocols yielded similar most abundant taxa: Cladosporium and Epiccocum (Supplementary 
Fig.  S1b). However, there did exist an influence of protocol on the data, as relative proportions 
of Cladosporium and Epiccocum varied between the two protocols, samples clustered separately 
by protocol on PCoA, and  overall community membership and structure were significantly 
different (ANOSIM R=0.3880, P=0.0370; Supplementary Fig.  S1c).   
Fungal Diversity Analyses of Baseline Allergic Canine Skin  
 Similar to the approach in healthy dogs, we were also interested in how body site or dog 
influenced the mycobiota of allergic skin in dogs. There was an overall significant effect of body 
site on richness (observed species, P<0.0001) and diversity (Shannon, P=0.030) of cutaneous 
mycobiota (Supplementary Table S1). Specifically the nostril was less rich (observed species, 
P<0.01) than the axilla, groin, interdigital, and lumbar sites, and less diverse (Shannon, P<0.05) 
than the axilla, groin, and interdigital sites. In addition, the ear in allergic dogs was both less rich 
(observed species, P<0.05) than the axilla, groin and lumbar, as well as less diverse (Shannon, 
P<0.05) than the interdigital space. In contrast to the findings in healthy dogs, there was no 
influence of the individual dog on the richness or diversity of the skin mycobiota. Exact values 
of alpha diversity for each body site and dog are reported in Supplementary tables S6 and S7. 
 Although there were no significant differences in beta diversity of cutaneous mycobiota 
between body sites in healthy dogs, differences between body sites in allergic dogs were 
identified. Fungal community membership (Bray Curtis) was significantly different in the nostril 
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compared to the axilla (R=0.331; P=0.015; Supplementary table S8), and interdigital space 
(R=0.441; P=0.015; Supplementary table S8). Fungal community structure (Yue-Clayton theta 
coefficient) was different between the nostril and axilla (R=0.294; P=0.030; Supplementary table 
S8), groin (R=0.213; P=0.030; Supplementary table S8) and interdigital space (R=0.300; 
P=0.045; Supplementary table S8). Similar to healthy dogs, the beta diversity was more 
dependent on the individual dog than body site (Fig.  2a) with 11 out of 28 comparisons between 
allergic dogs being significantly different with a median R-value of 0.306 for membership (Bray 
Curtis, median P<0.05; Supplementary table S4) and 0.297 for structure (Yue-Clayton theta 
coefficient, median P<0.05; Supplementary table S4). 
Shifts in Attributes of Cutaneous Mycobiota between Healthy and Allergic Dogs  
 For the comparison of mycobiota between healthy and allergic canine skin, only the 
‘health status’ was considered. First, differences in alpha diversity between the two groups were 
evaluated. The mycobiota of the nostril and ear from allergic dogs were less rich than their 
counterpart in healthy dogs (observed species, P<0.05 and, P<0.01; Fig.  5a). The mycobiota of 
the ear was the only allergic body site that was less diverse (Shannon, P=0.003; Fig.  5b) than the 
same body site in healthy dogs. Overall allergic canine skin was significantly less rich in fungal 
species compared to healthy canine skin (observed species, P<0.001; Fig.  5c), but not 







Figure 5. Comparison of alpha diversity and richness between healthy and allergic dogs. Means 
are marked with straight lines and mean error bars plotted using JMP. Significant differences 
between health statuses are denoted by asterisks (*P<0.05, **P<0.01, ***P<0.001). (a) The 
fungal richness of each body site was calculated with observed species, and are grouped by body 
site and health status. (b) The fungal diversity of each body site was calculated with Shannon, 
and are grouped by body site and health status. (c) The fungal richness of body sites was 
calculated with observed species, and are grouped by health status. (d) The fungal diversity of 




 We also wanted to know whether health status influenced beta-diversity. To accomplish 
this, ANOSIM was performed on the Bray-Curtis, Jaccard, and Yue-Clayton theta coefficient 
distance matrices. An overall significant effect of the factor 'health status' was identified with 
only the Jaccard distance matrix (Fig.  6a), which was mainly due to differences in cutaneous 
mycobiota between health status groups at three body sites: ear canal (R=0.249, P=0.026; 
Supplementary table S8), groin (R=0.264, P=0.024; Supplementary table S8), and interdigital 
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space (R=0.402, P=0.012; Supplementary table S8). These differences were visualized with 
PCoA plots that demonstrated clear clustering of allergic dog samples separate from healthy dog 
samples for individual body sites (Figs. 6b 6c and 6d). These findings were further supported by 
testing of individual taxa between the two health status groups done in JMP using the filtered 
relative abundance table (Supplementary Table S5), and through LDA Effect Size (LEfSe) 
analysis (Fig.  7).  
 
 
Figure 6. Dissimilarity between healthy and allergic skin fungal communities. (a) PCoA plot of 
all samples coming from the shared sites in healthy and allergic dogs. Dissimilarity in fungal 
community membership was estimated with the Jaccard metric in the Mothur package, and 3-D 
PCoA plots were generated in QIIME. Each dot represents a body site from one dog, with all 
healthy dogs colored in blue and all allergic dogs colored in red. (b) PCoA plot of only the ear 
samples for healthy and allergic dogs. (c) PCoA plot of only the groin samples for healthy and 







Figure 7. Differential abundances of fungal taxa between healthy and allergic canine skin.  (a) 
LDA Effect Size (LEfSe) analysis revealed 14 fungal taxa significantly more abundant in healthy 
skin, and 8 taxa more abundant in allergic skin. (b) Cladogram plotted from LEfSe analysis 
showing the taxonomic levels represented by rings with phyla in the innermost ring and genera 
in the outermost ring, and each circle is a member within that level. Those taxa in each level are 





 In addition to alpha and beta-diversity, differences in relative abundance of specific taxa 
were also identified between healthy and allergic dogs. Overall, there were 85 taxa found to be 
significantly increased or decreased in allergic skin when compared to healthy skin by the 
Kruskal-Wallis test performed in JMP (P<0.05; Supplementary table S5). Stacked bar plots were 
used to visualize changes in presence and abundance of fungal taxa between healthy and allergic 
skin at six body sites (Fig.  4c). LEfSe analysis identified twelve taxa that were more abundant in 
healthy dogs, and seven taxa that were more abundant in allergic dogs (Fig.  7). The genera that 
were increased in healthy skin included Blumeria, Wallemia, Candida, Schizophyllum and 
Exserhilum. The genera increased in allergic skin include Sporobolomyces, Hydnum, Irpex, 
Periconia, Cochliobolus, and Microascales. Furthermore, 50% of the allergic ears were 
predominated by one genus: 58% of the mycobiota in the ear of D13 was Malassezia, 94% of 
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D14 was Malassezia, and 99% of D17 was Sporobolomyces (Basidiomycete, Sporidiobolales 
family incerta sedis) (Fig.  4b). 
Discussion 
 Consistently throughout the diversity analyses, and comparison of relative abundances of 
fungal taxa, cutaneous mycobiota of the ten dogs sampled in this study were more dependent on 
the individual dog than the body site. Although the mycobiota associated with body sites were 
very similar within the dog, there existed a high degree of inter-dog variability. Human skin also 
exhibits a high degree of interpersonal variability,63 but unlike canine skin, as demonstrated by 
the current study, human cutaneous mycobiota were dependent on body site. Although body site 
was not a major influencing factor of cutaneous mycobiota in healthy dogs, we did find reduced 
fungal diversity at the mucosal sites. The mucosal sites in dogs, including the nostril and 
conjunctiva, are bathed in fluid and are also more protected from the environment, which could 
explain the reduction in richness, a finding that also exists for the bacterial microbiota of canine 
skin.80 
Several physiological differences exist between canine and human skin which may 
account for some of the differences noted between the mycobiota of the two species. Human skin 
has a varied topography and morphology, producing distinct dry, sebaceous or moist skin 
microenvironments,15 whereas canine skin is more uniform across areas of haired skin containing 
both sebaceous and apocrine glands.117 Additionally, canine skin is more acidic than human 
skin.118,119 There also exists differences in lipid content of the skin that could influence the 
colonization of cutaneous mycobiota.117   
 Other than skin morphology and topography, additional factors may be responsible for 
the differences in distribution of mycobiota observed between canine and human skin. These 
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include differences between human and animal behavior, hygiene habits, and amount of 
environmental exposure. It is generally well accepted that dogs are more exposed to outdoor 
elements than humans due to closer proximity to the ground, and behaviors such as rolling in the 
grass and laying on the floor inside the home where shoes track in environmental contaminants. 
In addition to greater environmental exposure, dogs are bathed less frequently than humans, 
which could enable colonization of more diverse fungi.  
The types of environmental exposure could affect beta-diversity of cutaneous mycobiota, 
which may explain the high degree of inter-dog variability. For example, dogs from different 
homes (and backyards) may have variable exposures to different types of trees, plants, grasses, 
and bodies of water, such as ponds, swimming pools or bayous. Contact with the floor inside a 
home is another type of environmental exposure that likely influences diversity. It is interesting, 
and possibly correlated, that the only areas of human skin possessing high fungal diversity are 
the feet,63 which are often in contact with the floor. Similarly, dogs spend most of their time 
laying their entire body on the floor, and a diverse mycobiota, as identified in this study, would 
be expected to colonize different regions of their bodies. Specifically, there was an abundance of 
Epicoccum on the feet of humans,63 and the current study found this particular taxa was also 
abundant on the skin of dogs. Additional indoor exposures, including cohabitation with other 
people or animals, can also influence the cutaneous microbiota.31 Further studies are required to 
find a true correlation between cohabitation and sharing of cutaneous mycobiota amongst human 
and animal members of the same household. 
 We also found that health status had a significant effect on the cutaneous mycobiota of 
dogs. Comparing the ten healthy dogs in this study to the eight dogs diagnosed with allergic skin 
disease, we found the skin of allergic dogs had reduced fungal richness. Additionally, allergic 
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ears, a site commonly infected in allergic dogs, had reduced fungal diversity as well. 
Interestingly, we identified differences in cutaneous mycobiota between body sites in allergic 
dogs, but not in healthy dogs. Also, the cutaneous mycobiota was more similar within a dog for 
healthy dogs than for allergic dogs. These findings taken together suggest that the stability of 
cutaneous mycobiota within a dog is disturbed by allergic skin disease, leading to changes at 
distinct body sites affected by this disease, and thus more pronounced body site differences in the 
allergic dogs. A similar phenomenon was observed for human primary immunodeficiency (PID) 
patients where the dependence of bacterial communities on body site in healthy individuals was 
diminished in the affected individuals.68  
 The significant changes identified for allergic skin in dogs who were not experiencing 
any observable clinical lesions at the time of sample collection suggests an association of fungal 
dysbiosis to the underlying mechanisms of allergic skin disease. In people, loss of function 
mutations to the filaggrin gene and resultant skin barrier dysfunction have been proposed as one 
of the most important factors in development of AD.120 Altered filaggrin expression has been 
identified for atopic dogs,121 along with transepidermal water loss, and decreased ceramide 
concentrations.122 It is possible that the reduced diversity we see in both bacteria and fungi living 
on non-lesional allergic canine skin could be attributed to skin barrier impairment in allergic 
dogs, or to changes in nutrient (water and lipid) availability in the skin caused by the allergic 
skin disease. Likewise, the chronic use of steroids, antibiotics, antifungals, fatty acids, and 
topical treatments in allergic dogs could alter the skin microbiota.  
 A previous study reported an increase in fungal diversity in lesional skin of atopic 
people.68 Although we did not find the same trend in our study, this may be attributed to the fact 
that the mycobiome of healthy human skin is naturally less diverse than healthy canine skin, and 
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predominated by one genus, Malassezia. The healthy human vaginal microbiota lacks bacterial 
diversity and is predominated by Lactobacillus.123,124 An increased diversity of anaerobic 
bacteria, coupled with a decrease in Lactobacillus, has been identified in bacterial vaginosis 
(BV) through NGS.123,124 In both of these cases of increased microbial diversity associated with 
diseased skin and mucosa (fungal microbiota in AD and bacterial microbiota in BV), the baseline 
or healthy microbiota is predominated by one genus, and a disturbance to the microbiota lead to 
a decrease of the major microbial resident allowing for invasion of other microbes, thus an 
increase in overall diversity. On the other hand, a disruption to an already diverse microbiota 
could allow for one or several microbes to increase in relative abundances, and predominate in 
lesional skin. Another possibility is that decreased microbial diversity was present in non-
lesional canine skin, but had lesional skin been sampled, an increase in diversity might have been 
observed. We plan to evaluate the differences between lesional and non-lesional canine allergic 
skin in future studies.  
 Although Malassezia has been implicated in both human and canine AD as an allergen 
and trigger of disease symptoms,95-98,100 we were unable to detect any significant differences in 
the relative abundance of Malassezia between healthy and allergic groups. Three ears were 
predominated by Malassezia (greater than 50% relative abundance), one from a healthy dog and 
two from allergic dogs. All dogs were examined by veterinarians and there were no reported ear 
infections at the time of sample collection; thus these would either represent asymptomatic ear 
infections or the invasion and predominance of one genus. Perhaps if more dogs had been 
sampled we would have seen a true significant increase in Malassezia for the allergic group. The 
relatively low abundance of Malassezia across all body sites was an unexpected finding since 
culture-based studies have reported Malassezia as being one of the most cultured fungi from 
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canine skin.110,125-127 This genus absolutely predominated in human skin in two NGS studies 
targeting the ITS63 and large rRNA subunit (LSU) regions.101 We ruled out the possibility of the 
extraction protocol influencing the amount of Malassezia detected through comparison of our 
extraction protocol to that of the Findley et al. 2013 protocol, and found no significant 
differences in the amount of Malassezia.  
 Our results demonstrate a very rich mycobiome compared to human skin with a 
predominance of Dothideomycetes such as Alternaria, Cladosporium and Epicoccum. These 
three genera are responsible for environmental allergies in two groups of people: 20-30% of 
atopic people, and 6% of the general population (non-atopic people).128 In addition to serving as 
human allergens to hypersensitive people, these fungi are also known allergens for atopic 
dogs,129 and have been identified in house dust.130 Interestingly, the relative abundances of 
Alternaria and Cladosporium were significantly different between dogs (Supplementary Fig. S3) 
and future studies may help to elucidate why the skin of some dogs harbor more of these 
allergenic fungi than do others, and whether carriage of these fungi on dogs could impact 
humans or dogs who are hypersensitive to these fungi. Furthermore, it is possible that 
cohabitation with dogs, whose skin is inhabited by these allergenic fungi, at an early age could 
de-sensitize children to fungal allergens and possibly protect against the development of allergies 
to these fungi.131 Another possible mechanism for desensitization to the allergenic fungi present 
on the coat of dogs is through fetal exposure in a pregnant mother who cohabits with dogs.132,133  
 In summary, next generation sequencing of canine skin has revealed a much more diverse 
cutaneous mycobiota than what was previously described with culture-based techniques. The 
cutaneous mycobiota appear to be influenced by various factors including environmental 
exposure, cohabitation with other pets and skin health status. Since the majority of the dogs in 
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our study came from separate households and were different breeds, the high degree of inter-dog 
variability could be explained by differences in environmental exposure, genetic differences 
between breeds, or pelage characteristics. Our study only included 18 dogs and so the influence 
of these factors should be confirmed with future studies having increased numbers of animals 
and evaluating each factor separately. The host-microbiome interaction in allergic dogs also 
warrants investigation through immunologic and metagenomic studies, as we have now seen 
both the bacterial and fungal microbiota in non-lesional canine allergic skin disease are 
disrupted, with increased abundances of particular taxa present in the allergic skin, and an overall 
reduction in microbial diversity. The predominant fungal taxa inhabiting the skin of dogs suggest 
human cohabitation with dogs could have an effect on sensitization to fungi, and other microbes, 




CHAPTER III 2 
FELINE CUTANEOUS MYCOBIOTA 
Introduction 
 In the midst of the microbiome revolution, next-generation sequencing (NGS) 
technologies have provided a methodology to more comprehensively characterize host-
associated microbial communities (microbiota), and have revealed a much more diverse 
microbiota than what was previously thought to exist (Human Microbiome Consortium).88 In 
humans, NGS studies have shown that skin-associated bacterial microbiota are distributed 
according to physiological niches,15 such as dry, moist, and sebaceous skin microenvironments,21 
whereas the distribution of the fungal microbiota (mycobiota) is more dependent upon body site 
location such as core body versus feet.63 In contrast to what is observed in people, the bacterial 
microbiota on canine skin do not prefer physiological niches, but are instead influenced by body 
site.80 The mycobiota are more likely to be distributed evenly across body sites within a dog, and 
significant differences in mycobiota are observed between dogs.134  
The specific bacterial and fungal taxa present on canine skin differs from those present on 
human skin. Canine skin is predominated by bacteria in the phylum Proteobacteria, Firmicutes 
and Actinobacteria,80 and environmental fungi such as Alternaria and Cladosporium,134 whereas 
human skin is more abundantly colonized by bacteria in the phyla Actinobacteria and 
Firmicutes,21 and the fungal genus Malassezia.63 Hygiene practices and environmental exposures 
are thought to contribute to the differences in diversity and taxa between host species,134 
although studies are still required to better investigate their influence on the microbiome. To 
                                                 
2 Meason-Smith C, Diesel A, Patterson AP, et al. Characterization of the cutaneous mycobiota in 




date, the microbial communities present on feline skin have only been investigated using culture-
dependent methods.108,135-143 The results of these studies are variable, and fungal genera 
commonly isolated include Penicillium, Cladosporium, Aspergillus, Alternaria and Malassezia. 
Inclusion of study participants diagnosed with atopic dermatitis (AD), or more broadly an 
allergic dermatitis, into these NGS studies enables the comparison of skin-associated microbiota 
between a healthy skin environment, and one affected by skin barrier impairment, immunologic 
dysfunction, altered epidermal kinetics or epidermopoiesis (migration of nucleated cells from the 
stratum basale to anuclear cornified cells in the stratum corneum), and inflammation as seen in 
these disease processes. Bacterial and fungal dysbiosis (alteration to the normal microbiota) has 
now been identified in both human AD,68,91 and canine allergic dermatitis.80,134 The lesional skin 
of human atopic patients possesses a reduced bacterial diversity, with proportionate increases in 
Staphylococcus species,91 and increased fungal diversity.68 On the contrary, non-lesional skin of 
allergic dogs possessed reduced diversity of both bacterial and fungal microbiota.80,134  
 Cats also suffer from an allergic dermatitis sometimes resembling human and canine AD, 
referred to as nonflea nonfood induced hypersensitivity dermatitis (NFNFIHD), suggesting 
triggers of the environment as the cause of allergic skin disease.144 However, the pathogenesis of 
NFNFIHD is incompletely understood and to our current knowledge does not share some of the 
defining characteristics of human and canine AD.145,146 These include the lack of proven genetic 
predisposition for any subgroup of NFNFIHD, except for three littermates,147 clinical 
presentation,148 and uncertainty as to whether the skin barrier is impaired in NFNFIHD. 
Furthermore, there has been variable reports on the role of IgE to environmental allergens in 
NFNFIHD.149,150 To date the skin microbiota of NFNFIHD cats has yet to be investigated with 
either NGS or culture-dependent methods. Only a single study using cytologic examination of 
 
 49 
tape strips demonstrated an overgrowth of Malassezia in allergic cats compared to control 
cats.140  
 The goals of this study were to characterize the mycobiota of feline skin using NGS, and 
to determine whether alterations to the mycobiota exist in allergic feline skin. Similar to previous 
studies, the influence on the mycobiota of skin physiology, body site, and individual was 
assessed for healthy and allergic cats. The overall fungal diversity and relative abundances (the 
amount of a fungal taxon sequenced in a sample relative to the total amount of fungal DNA 
sequenced for that sample) of select taxa were compared between healthy and allergic feline 
skin. It was hypothesized that the mycobiota of feline skin would be similar to canine skin, and 
that fungal dysbiosis would also exist in feline allergic dermatitis. 
Materials and methods 
Subject recruitment 
 All samples for this study were collected following a protocol approved by the Texas 
A&M University Institutional Animal Care and Use Committee. Eleven cats (C1-C11) were 
enrolled in this study on the basis of no current or prior dermatological conditions, as determined 
by a board certified veterinary dermatologist, and were assigned to the healthy group (Table 2). 
These cats ranged from 2 to 17 years of age, five were castrated males and six spayed females, 
and there were six domestic shorthairs, two domestic mediumhairs, and three domestic longhairs.   
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Previous antibiotics usage 
C1 Healthy DLH 5 MC Y 100 n/a n/a N 
C2 Healthy DSH 2 FS N 100 TFB n/a N 
C3 Healthy DSH 13 MC N 100 CTFB n/a N 
C4 Healthy DSH 7 MC N 70 TFB TGW N 
C5 Healthy DMH 4.5 FS N 99 CTFB TGW N 
C6 Healthy DSH 7 FS N 100 TFB n/a N 
C7 Healthy DSH 9.5 FS N 50 B TGW N 
C8 Healthy DLH 13 FS N 100 CTFB n/a N 
C9 Healthy DLH 15 FS Y 0 n/a TGW N 
C10 Healthy DMH 6 MC N 100 CTFB n/a N 
C11 Healthy DSH 17 MC N 100 CTF n/a N 
C12 Allergic DSH 9 MC N 100 TFB n/a N 
C13 Allergic Sia 8 MC N 100 TFB n/a N 
C14 Allergic DSH 11 MC Y 95 CFB TGW N 
C15 Allergic Sia 9 FS N 100 TFB n/a N 




Table. 2 Continued 




Previous antibiotics usage 
C17 Allergic DSH 9 FS N 100 CTFB n/a N 
C18 Allergic Per 4 MC Y 100 CTB n/a Y 
C19 Allergic DSH 7 FS N 100 CTFB n/a N 
C20 Allergic DSH 8 FS Y 95 TFB TGW N 
Fleas and ear problems were part of the medical history and not present at the time of sample collection. 
Abbreviations. Signalment: DLH-Domestic long hair, DMH-Domestic medium hair, DSH-Domestic short hair, Per-Persian, Sia-Siamese, MC-Castrated male, 




An additional nine cats (C12-C20) were also evaluated by a board certified veterinary 
dermatologist and were included in the allergic cat group (Tables 2 and 3). The allergic cats 
ranged from 4 to 11 years of age, and included four castrated males and five spayed females. The 
breeds of allergic cats included six domestic shorthairs, two Siamese, and one Persian. Cats were 
included in this group based on the diagnosis of a hypersensitive dermatitis (HD), and exclusion 
of other pruritic dermatoses caused by ectoparasites and bacterial or fungal infections.  
The classification of HD for each cat is presented in Table 3: flea bite hypersensitivity (FBH, 
n=8), food induced hypersensitivity (FIHD, n=1), and nonflea nonfood induced hypersensitivity 
(NFNFIHD, n=4). Four cats were diagnosed with more than one type of HD, and one cat had 
been diagnosed with FBH whose pruritus was not completely resolved with appropriate 
adulticidal flea prevention, but had not completed a food trial and thus was classified as also 
having nonflea bite hypersensitivity (NFBH). The age of onset of lesions ranged from 3 to 6 
years of age, with two cats that experienced a gradual progression of clinical signs with an 
unknown exact age of onset. Most cats (7/10) did not experience seasonal exacerbation of signs 
except for one that had flares during the summer only, and two that experienced flares during the 
spring and summer. The most common clinical signs included pruritus and self-induced alopecia. 
There was a wide range of lesion distribution (Table 3). Six cats had documented steroids usage, 
but only two (C14 and C15) were receiving steroids at the time of sample collection. 
Additionally, three cats were receiving therapies including oral cyclosporine (C15 and C16) 




Table 3. Hypersensitivity classification, age of onset, seasonality, clinical signs and distribution, and treatments for nine allergic cats.  
 
Cat Breed Age Type of HD Age of 
onset 







C12 DSH 9 FBH 6 N Pruritus, self-induced 
alopecia 
Limbs N N N 
C13 Sia 8 FBH 6 N Pruritus, self-induced 
alopecia 
Dorsum N N N 
C14 DSH 11 FBH G Summer Pruritus, self-induced 
alopecia crusting 
Rump, tail, ears, 
ventral abdomen 
Y N Y 






Face, neck, ears Y Cyclosporine Y 
C16 DSH 5 FBH, 
NFNFIHD 









C17 DSH 9 FBH, 
NFNFIHD 















Y N N 
C19  DSH 7 NFNFIHD 6 N Pruritus, cervicofacial Face, ears N N Y 








Table 3. Continued 
Allergy treatments were concurrent. All cats with a Y in the steroids column had previously received steroids, except for C14 and C15 that were receiving 
steroids at the time of sampling. C18 was diagnosed with a ringworm infection, treated with lime sulfur dips, and lesions resolved three months prior to sample 
collection. 
DSH-Domestic short hair, Per-Persian, Sia-Siamese, FBH-Flea bite hypersensitivity, FIHD-Food induced hypersensitivity, NFNFIHD- Non-flea non-food 







All healthy cats had not received systemic antibiotics or antifungals in the preceding six 
months, allergic cats in the preceding one month, and none of the cats had been bathed in the 
week prior to sample collection. Furthermore, no cats sampled showed any signs of secondary 
bacterial or fungal infections at the time of collection. 
Sample collection and DNA extraction 
 Twelve body sites were sampled on healthy cats including axilla, chin, conjunctiva, 
dorsal nose, dorsum, ear canal, groin, interdigital space, nostril, oral cavity, preaural space, and 
reproductive tracts. Only six sites, commonly affected by allergic signs, were sampled on allergic 
cats and included axilla, ear canal, dorsum, groin, interdigital space, and nostril. Samples were 
collected by rubbing sterile skin swabs against skin, DNA was extracted and stored as previously 
described.134  
ITS Sequencing and sequence analysis 
Illumina sequencing of all samples was performed on a MiSeq instrument at the XXXX, 
using the ITS1F (5’- CTTGGTCATTTAGAGGAAGTAA-3’) and ITS2R (5’- 
GCTGCGTTCTTCATCGATGC-3’) primers that amplify the internal transcribed spacer (ITS-1) 
region, a non-coding segment of genome found within the ribosomal genes of all eukaryotes. 
Sequences from only the forward reads were then processed in the open-source bioinformatics 
software Quantitative Insights into Microbial Ecology, QIIME.8 Quality filtering was performed 
and operational taxonomic units (OTUs; group of similar sequences that represents a taxonomic 
unit of a fungal species or genus) generated using the open reference picking command, and the 
Findley et al. 2013 ITS sequence database.63 Taxonomic assignments were made with a 
formatted version of the Findley et. al. 2013 ITS taxonomy file. OTU tables were rarefied at 
3100 sequences for healthy only samples, 5000 for allergic only samples, and 3300 for the table 
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including only the six sites sampled in both healthy and allergic cats. Alpha diversity was 
measured using Chao1, observed OTUs, and Shannon metrics. Beta diversity was measured 
using weighted Jaccard, Bray Curtis, and Pearson metrics.  
Statistical Analysis 
All statistical analyses were completed as previously described,134 except that distance 
matrices and relative abundance tables were generated in QIIME. The relative abundance tables 
were combined for all taxonomic levels (Phylum, Class, Order, Family and Genus) and filtered 
to include taxa present at greater than 1% in at least 3 samples for allergic cats, or 5 samples for 
healthy cats. Data was tested for normality, and Kruskal-Wallis tests were performed to 
determine whether the mean value (relative abundance or alpha diversity) of at least one cat or 
body site was significantly different from all others (P < 0.05). When significant, a Steel-Dwass 
all pairs test was performed to identify the cat(s) or body site(s) with significant differences 
(JMP). A Mann-Whitney test was performed to determine significant differences between health 
statuses (JMP). To determine whether the beta diversity of samples was significantly influenced 
by cat, body site, skin physiology, steroids, or healthy status, the analysis of similarities 
(ANOSIM) function in the statistical software PRIMER 6 (PRIMER-E Ltd, Luton, UK) was 
performed on the distance matrices generated in QIIME using the Jaccard, Bray Curtis, and 
Pearson metrics. The combined and filtered relative abundance tables were also used in linear 
discriminant analysis (LDA) effect size (LEfSe)115 to determine significant differences between 
cats, body sites, or health statuses. All P-values were corrected for multiple comparisons using 
the Benjamini and Hochberg false discovery rate.116 





 One hundred thirty two samples were collected from healthy cats, and 54 from allergic 
cats. Due to low number of sequences (less than 3000), 24 samples from healthy cats and 15 
from allergic cats were removed from downstream analyses. Following quality processing, the 
total number of sequences from the remaining healthy samples was 7,249,611, with a median of 
42,742 sequences per sample. The total number of sequences from allergic samples was 
2,521,229, with a median of 49,684 sequences per sample.  
Skin Fungal Diversity Analyses of Healthy Cats 
 The alpha diversity (diversity within a sample) of fungi sampled from feline skin was 
estimated using three different alpha diversity metrics. The observed OTUs estimator measures 
the number of OTUs per sample, which is thought to be a close representation of the number of 
fungal species present (i.e. fungal richness), the Chao1 estimator is a richness estimator that 
accounts for sequencing depth (likelihood OTUs were not identified in acquired sequencing 
data), and the Shannon Index is a diversity measure that accounts for OTU abundance and 
evenness. To determine whether fungal richness and diversity of skin microbiota was different 
between cats, body sites or skin physiologies, the alpha diversity measures for each metric were 
analyzed across all body sites within a cat (‘Cat’), across all cats at one body site (‘Body Site’), 
or for all body sites within a skin physiology category (‘Skin Physiology’) (Supplementary table 
9).  
 For healthy cats, there was a significant difference in fungal richness and diversity 
between cats (Observed OTUs, P<0.001; Shannon, P=0.022), and body sites (Observed OTUs, 
P=0.044; Shannon, P<0.0001). Specifically, the skin of C9 harbored a more rich and diverse 
mycobiota than other cats (Figure 8). The conjunctiva and reproductive tracts of healthy cats 
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were the least diverse body sites, while the preaural space was the most rich and diverse (Figure 
8). Fungal diversity was also significantly different between skin physiologies (Shannon, 
P<0.0001), with the mucosal sites (including conjunctiva, nostril and reproductive tracts) being 





Figure 8. Alpha diversity of healthy cats. a-c: Alpha diversity estimated with observed OTU’s 
and samples grouped by (a) cat, (b) body site, and (c) skin physiology. d-f: Alpha diversity 
estimated with Shannon diversity metric, and samples grouped by (d) cat, (e) body site, and (f) 
skin physiology. Means and mean error bars are plotted in blue for each group. Groups with a 
mean significantly different from other means are denoted by asterisks, with associated P-values 
(Steel-dwas multiple comparisons test, of *<0.05, **<0.01, ***<0.001. A-axilla, C-chin, CJ-
conjunctiva, DN-dorsal nose, D-dorsum, EC-ear canal, G-groin, ID-interdigital space, N-nostril, 




The beta diversity (diversity between samples) of feline skin mycobiota was estimated 
using three different non phylogenetic based metrics. The Jaccard estimator is calculated by 
comparing the presence of shared fungal taxa between samples, while the Bray Curtis and 
Pearson estimators further account for differences in amounts of fungal taxa between samples. 
These calculations are performed for each possible pair of samples, and the distance matrix 
generated is then used to create the 3-dimensional PCoA plots. ANOSIM was performed on the 
distance matrices to determine statistical significance of a factor (cat, body site, skin physiology) 
on the dissimilarity between samples.    
The results of performing ANOSIM on the distance matrices generated by all three 
metrics produced comparable results as demonstrated in Figure 9. The R statistic indicates the 
effect a variable has on the dissimilarity between samples. This value ranges from zero to one, 
with an R value of one indicating complete dissimilarity between two groups within a factor (e.g. 
axilla and groin are the groups, body site is the factor). An R value of one would also indicate 
that factor has a very strong influence on the presence and/or abundance of mycobiota. R values 
are calculated for each pairwise comparison between groups (significant comparisons 
summarized in supplementary table 10), and a global R statistic is calculated for the factor under 
study (cat, body site, skin physiology).  
 Some clustering of healthy cat samples (n=108) by cat can be observed in the PCoA plot 
of the Bray Curtis pairwise distances between healthy cats, indicating similarity of fungal 
communities in the sites that cluster together (Figure 9; ANOSIM, R=0.324, P=0.001). Nineteen 
of the pairwise comparisons between cats were significantly different, with an average R value 
of 0.215 and P-values ranging from 0.003 to 0.038 (Supplementary table S10). Clustering was 
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less apparent by skin physiology (Figure 9; ANOSIM global R=0.208; P=0.002), and absent by 





Figure 9. Beta diversity of healthy cats. (a) Comparison of ANOSIM global R statistic between 
three metrics, Jaccard, Bray Curtis and Pearson for the factors of cat and body site in both health 
status groups. (b-d) PCoA plot of Bray Curtis pairwise distances for healthy cat samples,with  
associated ANOSIM global R statistic, and P-value; colored by (b) skin physiology, (c) cat, and 




Skin Fungal Taxonomic Composition of Healthy Cats 
 The most abundant fungal phylum identified was Ascomycota accounting for 79% of 
fungal sequences from healthy cats, and the most abundant class within this phylum was 
Dothideomycetes accounting for 48% of healthy sequences. The three most abundant genera 
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within this class were Cladosporium, Alternaria, and Epicoccum (Figure 10). There was also a 
remarkable amount of fungal sequences (21%) that were classified within the Ascomycota 
phylum, but could not be classified further (Figures 10 and 11; Other Ascomycota). The most 
abundant genus within the Basidiomycota phylum was Cryptococcus. Although these were the 
most abundant taxa across healthy sites sampled, a high degree of variability between samples 
was noted, as presented in the taxa plots of Figure 11. Malassezia was sequenced from 30% of 
healthy cat samples (n=35), but was present at greater than 1% relative abundance in only 5% of 
samples (n=6) (Supplementary figure S2). The median relative abundance of unassigned 
sequences was 6%, however there were several samples that had greater than 50% of unassigned 
sequences. Due to the fact fungal databases are still undergoing curation, these sequences may be 








Figure 10. Fungal taxonomic composition of healthy cat body sites. The relative abundances of 









Figure 11. Fungal taxonomic composition of healthy and allergic feline skin. (a-b) Relative 
abundance of fungal taxa are presented for each sample, and colored by fungal genus. (c) 
Comparison of most abundant fungal genera between healthy and allergic skin, averaged for 




Two types of statistical testing, Kruskal-Wallis and LEfSe, were performed to determine 
whether specific taxa (phylum, class, order, family, or genus levels) were differentially abundant 
between cats or body sites. Kruskal-Wallis testing performed in JMP revealed that the relative 
abundance of 53 taxa were significantly different between cats (Supplementary table S11; FDR 
adjusted P<0.05), only two taxa were significantly different between body sites, and eight taxa 
were different between skin physiologies. The relative abundance of the three most abundant 
fungal genera on the skin of healthy cats, Cladosporium, Alternaria, and Epicoccum, were 
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significantly different between cats (Supplementary table S11). LEfSe analysis did not identify 
any significant differences in fungal taxa between healthy cats or body site.  
Skin Fungal Diversity Analyses of Allergic Cats 
 Alpha diversity was estimated for allergic samples with the Chao1, Observed OTUs 
(fungal richness), and Shannon (fungal diversity) metrics and all median values are found in 
Supplementary table 12. No significant differences in fungal richness or diversity between 
allergic cats, nor between allergic body sites (Supplementary figure S3) were identified with 
Kruskal-Wallis tests. Similar to healthy cats, allergic cats possessed reduced fungal diversity at 
the mucosal sites (conjunctiva, nostril and reproductive) (Supplementary figure S3; Kruskal-
Wallis, P<0.05). No differences in fungal richness or diversity were identified between allergic 
cats that had received, or were currently receiving steroids, and allergic cats that had never 
received steroids (Supplementary figure S3).  
The beta diversity of allergic cat samples (n=43) were calculated using the weighted 
Jaccard, Bray Curtis and Pearson metrics to determine if there were any differences between 
cats, body sites, skin physiologies and steroid usage. PCoA plots revealed some clustering of 
sites by cat (Supplementary figure S4; ANOSIM, R=0.324, P=0.001), but no clustering by body 
site. Although the ANOSIM R statistic was low for steroid usage (R=0.100, P=0.020), sample 
clustering is visually apparent in the PCoA plot of Bray Curtis pairwise distances between 
allergic cat samples. Skin physiology did not have a major effect on differences in beta diversity 
between allergic samples (Supplementary figure S4; ANOSIM, R=0.208, P=0.047). ANOSIM 
performed on the Bray Curtis distance matrix for allergic cat samples revealed that the beta 
diversities of six pairs of cats were significantly different with an average R value of 0.370 and 
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FDR adjusted P-values of 0.041 (Supplementary table S10). No pairwise comparisons of allergic 
body sites were significantly different for any beta diversity metric.  
Skin Fungal Taxonomic Composition of Allergic Cats 
 The most abundant fungal phylum sequenced from the skin of allergic cats was 
Ascomycota accounting for 77% of all sequences, and the most abundant class within this 
phylum was Dothideomycetes, accounting for 34% of sequences (Figures 9 and 10). The three 
most abundant Ascomycete genera were Cladosporium, Alternaria and Nigrospora. The most 
abundant Basidiomycete genus was Cryptococcus. Malassezia was sequenced from 21% of 
allergic cat samples (n=8), but was present at greater than 1% relative abundance in only one 
sample (Supplementary figure S2).  
Kruskal-Wallis tests were performed on taxa present in at least three samples with a 
relative abundance of greater than 1% to determine whether they were differentially abundant 
between allergic cats, or between body sites. Six taxa were differentially abundant between 
allergic cats, but no taxa were identified as significantly different between body sites 
(Supplementary table S13). Two of the genera that were significantly different between cats were 
Arthroderma (sexual stage of Microsporum, causative agent for dermatophytosis) and Fusarium 
(Supplementary figure S5). Arthroderma and Fusarium were more abundant on C18 compared 
to other cats. These results were further corroborated in LEfSe analysis that revealed Fusarium 
as a taxon significantly more abundant on C18 compared to all other cats (Supplementary figure 
S6; LDA score of 5). LEfSe analysis also showed that an unclassified Tremellales genus, phylum 
basidiomycete, was more abundant on the dorsum of allergic cats compared to other body sites 
on allergic cats (Supplementary figure S6; LDA score of 4.5).  
Comparison of Skin-associated Fungi between Healthy and Allergic Cats 
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 For the comparison of fungi colonizing the skin of healthy cats to that of allergic cats, 
only the six shared sites (axilla, dorsum, ear canal, groin, interdigital space and nostril) were 
included in the following analyses. For these sites, the estimated alpha diversities were not 
significantly different between the two groups (Supplementary figure S7 and supplementary 
table S14), and neither were the estimated beta diversities influenced by health status overall 
(Supplementary table S15). However, the Jaccard pairwise comparisons at two sites were 
significantly affected by health status: axilla (ANOSIM, R=0.378, FDR adjusted P=0.03), and 
interdigital space (ANOSIM, R=0.255, FDR adjusted P=0.036). Clustering by health status can 









Figure 12. Comparison of beta diversity between healthy and allergic skin. PCoA plots of 
Jaccard pairwise distances for healthy and allergic feline skin samples, with associated ANOSIM 
global R statistic and associated P-value for (a) six sites, (b) only the interdigital spaces, (c) only 




Only fungal taxa that were present in at least three samples with a relative abundance of 
greater than 1% were analyzed by Kruskal-Wallis tests and LEfSe to determine if any taxa were 
differentially abundant between health statuses. The Kruskal-Wallis tests revealed that nine taxa 
were significantly different between health statuses including the genera Epicoccum and non-
classified Capnodiales order (Supplementary table S16), which were also identified as 
significantly more abundant in the healthy group by LEfSe analysis (Figure 13; LDA score of 4 
to 5). The classes Agaricomycetes and Sordariomycetes were also identified as significantly 
different between health statuses (Supplementary table S16), and LEfSe analysis found these 
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classes to be significantly more abundant in the allergic group (Figure 13; LDA score of -3 to -
4). Figure 10 visually demonstrates differences in averages of fungal taxa between healthy and 





Figure 13. LDA effect size (LEfSe) analysis of healthy and allergic cats. Fungal taxa that are 
significantly increased or decreased in healthy or allergic skin are presented in two forms- as bar 
blots showing the LDA score, and as a cladogram demonstrated the phylogenetic relationships.  






 Similar to what has been previously reported in dogs,134 this study demonstrated that 
fungi colonizing the skin of cats tended to be similar across the entire body of the cat, with 
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differences observed between cats. It is possible that the grooming habits of cats may influence 
the dissemination of mycobiota across the entire body of the cat. This study also identified 
reduced diversity at the mucosal sites, and a predominance of Dothideomycetes (Cladosporium, 
Alternaria, and Epiccocum), similar to what was found for canine skin. While it is not possible to 
quantitatively compare the results of two NGS studies, qualitatively the diversity of fungi 
sequenced from feline skin appears to be comparable to that of canine skin,134 and much more 
diverse than what has been found on the human body, except at the pedal sites.63 A previous 
study suggested that outdoor exposures might explain the predominance of environmental fungi 
sequenced from the skin of dogs,134 however, the same taxa of fungi were also abundant on cats, 
many of which, in this study, were strictly indoor (13/20). Further studies are warranted to 
evaluate how outdoor exposures might influence the colonization of fungi on the skin of 
companion animals.  
 Aside from the influences on diversity of fungi inhabiting the skin of people and animals, 
there remain many questions regarding the temporal stability of these fungi on animal skin. One 
of the cats in this study was diagnosed with dermatophytosis a few months prior to collection of 
samples for this study. The skin lesions in this cat resolved with application of lime sulfur dips 
and no clinical signs were observed at the time of sample collection. Statistical analysis of the 
relative abundances of fungi sequenced from the skin of this cat compared to the skin of other 
cats revealed significantly higher amounts of the fungus Arthroderma, which is the sexual stage 
of Microsporum, one of the causative agents of dermatophytosis. Although this finding was 
isolated to one cat, combined with its clinical history, this indicates the possibility of 
dermatophytosis causing long term effects to the skin mycobiota across the entire cat. This 
finding also raises continued concern regarding a potential carrier state for dermatophytosis in 
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cats,151 and demonstrates the ability of NGS to detect this state in the absence of clinical signs. 
Additional studies including increased numbers of animals would certainly be required in order 
to confirm long term alterations to the fungal skin microbiota and a carrier state following 
resolution of lesions. This finding also offers evidence in support of the sampling and sequencing 
techniques used in this study, and others like it, suggesting representative sampling of the skin 
microbiota rather than transient environmental contamination. Interestingly, this cat (C18) also 
had a significant increase in Fusarium DNA across all of its body sites, compared to other cats. 
The relationship between colonization of Fusarium and Arthroderma, may also be of interest for 
future studies.  
Malassezia has been implicated as a significant allergen in human96,97 and canine AD,100 
however has yet to be associated with feline HD. Several studies have cultured Malassezia spp. 
from the skin of healthy cats137,152 and cats with otitis.108,136,138,141 In one of these studies 
Malassezia was cultured from approximately 40% of healthy cats.136 In the present study, 
Malassezia DNA was sequenced from around 30% of healthy cat samples, but at a low 
abundance relative to all fungi sequenced. There has also been documented breed differences in 
the type and amount of Malassezia colonization of feline skin; in a study including 73 cats, 
Malassezia was isolated from 90% of Devon Rex cats, 39% of Cornish Rex cats, and 50% of 
domestic short hair cats.152 Another study identified an overgrowth of Malassezia spp. from the 
skin of allergic cats using cytological examination of tape strips.140 We were not able to replicate 
these findings in the current study; Malassezia was sequenced from 21% of allergic cats, and no 
significant difference in abundance of Malassezia was identified between healthy and allergic 
samples. A previous NGS study of healthy and allergic canine skin also reported an 
unexpectedly low abundance of Malassezia.134 Future studies including additional methodologies 
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may be required to confirm the relative abundances of Malassezia spp. on the skin of companion 
animals and whether there exists any increased relative abundances of Malassezia on the skin of 
allergic animals. 
The allergic cats enrolled in this study were diagnosed with a range of HD including flea 
bite hypersensitivity (FBH), nonflea nonfood induced HD (NFNFIHD), and combinations of 
FBH and NFNFIHD in the same cat. The lesion distribution was also varied amongst study 
participants, but in accordance with typical cutaneous reaction patterns associated with the type 
of HD experienced by that cat. Although the allergic cats in this study were affected by varying 
etiological triggers of HD with varying lesion types/distributions, there were still some 
significant changes to the mycobiota of their skin as a group, namely the increase or decrease of 
particular fungal taxa. Fungal dysbiosis has also been identified in both canine and human 
AD,68,134 and fungal richness and diversity has differed between species, with previous studies 
showing increased fungal diversity in human atopic patients, and reduced fungal richness in 
allergic dogs. Unlike in dogs with allergic dermatitis,134 there was not an overall reduction in 
fungal diversity in the allergic cats.  Some factors that might explain this discrepancy include the 
differences in distribution and phenotypic presentation of lesions between canine AD and 
NFNFIHD in cats,153 or differences in immune regulation of the skin in these two species. 
Another possible explanation could be related to lack of skin barrier impairment in allergic cats, 
which is often described in atopic dogs154 and people.120 There has yet to be any studies to 
provide evidence for or against the impairment of the skin barrier in allergic cats, nor has there 
been any studies comparing the transepidermal water loss between healthy and allergic cats.  
 A complex dialog between skin microbiota and host immune system is known to 
occur.25,155 For instance, the host commensal microbiota is capable of inducing expression of 
 
 72 
antimicrobial peptides,156 which can then alter or modulate the presence and abundance of 
certain skin microbes. There is still debate as to whether microbial dysbiosis observed in 
inflammatory skin disorders is the cause of it, or rather an effect of, immune dysfunction. 
Regardless, microbial dysbiosis identified in canine allergic dermatitis and the results of this 
study in allergic cats, suggest that there is some alteration to this dialog between host and 
commensal microbiota in allergic dermatitis of companion animals.  
 In summary, NGS performed on skin swab samples of healthy and allergic feline skin 
identified a diverse mycobiota with predominances of environmental fungi such as 
Cladosporium, and Alternaria. These findings correlate well with what has been shown through 
culture dependent studies of feline skin,135,136,139,142,143 and NGS studies of canine skin.134 The 
mucosal sites, including conjunctiva, nostril and reproductive sites, harbor fewer fungal species, 
while the preaural space harbored the most. Fungal dysbiosis was identified for allergic feline 
skin, which was colonized by increased abundances of the fungal classes Agaricomycetes and 
Sordariomycetes, and decreased amounts of the fungal genus Epicoccum, one of the most 
abundant fungi on the skin of healthy cats. Fungal and bacterial dysbiosis has also been reported 
for allergic canine skin, with reduced numbers of microbial species present on the skin of allergic 
dogs compared to healthy dogs.80,134 One of the most interesting and unexpected findings from 
this study was the widespread distribution of dermatophyte DNA across the entire body of one 
cat that had a history of dermatophytosis, but no clinical signs at the time of sample collection. 
Further studies with larger numbers of animals are needed to confirm these findings, and to 
evaluate the role of the environment on the skin microbiota. For the skin of cats, NGS has 
enabled confirmation of culture dependent studies, while also providing novel and exciting data. 
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Investigation into the immune regulation of feline skin, and pathogenesis of feline NFNFIHD 




MALASSEZIA DYSBIOSIS IN CANINE ALLERGIC DERMATITIS 
 
Introduction 
 Next-generation sequencing (NGS) technologies have revolutionized the study of skin 
microbiota. Perturbations to the commensal microbiota (dysbiosis) are associated with numerous 
cutaneous diseases.18 Inflammatory conditions such as human and canine atopy have been of 
particular interest owing to secondary infections affecting diseased individuals.157 Recent studies 
have shown that for both human and canine atopy flares of inflammation coincide with 
increasing abundances of Staphylococcus and progression of lesions.85,91,158 Looking beyond the 
bacterial microbiota, dysbiosis of fungal microbiota (mycobiota) has now been documented in 
human atopy,71 psoriasis,70 chronic wounds,69 seborrheic dermatitis159 and canine allergic 
dermatitis.134 These cutaneous diseases are often multifactorial and are thought to involve an 
interplay between the host, environment, and microbiota. However, much is still unknown 
regarding the exact mechanism of disease pathogenesis.57,58,74,160  
 While many parallels exist between human and canine atopy including transepidermal 
water loss (TEWL), ceramide alterations, and microbial dysbiosis,74,157 there are some clinical 
aspects that are unique to canine atopy. For example, many atopic dogs will develop secondary 
Malassezia dermatitis or otitis as a chronic and recurrent feature of their disease.74 Over time a 
recurrent otitis externa will lead to hyperproliferation of the ear canal ultimately resulting in 
mineralization and the need for removal of the ear canal in a surgical procedure known as a 
TECABO, total ear canal ablation and bulla osteotomy. Malassezia pachydermatis is the 
etiologic agent of secondary yeast infections in allergic dogs, and previous work has 
demonstrated M. pachydermatis is more abundant on the skin of dogs with allergies by both 
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culture,110 and cytology.161 One proposed explanation for the prevalence of Malassezia infections 
in atopic dogs is simply that these dogs harbor more M. pachydermatis on their skin.  Other 
research has focused on pathogen virulence traits and found an association between strains that 
produce specific phospholipases and severity of disease.162-165 
 Our lab conducted the first fungal NGS study on healthy and allergic dogs, and did not 
find an increased relative abundance of Malassezia on the skin of non-lesional allergic dogs.134 
The discrepancy between our results and other culture-dependent studies demonstrating 
increased Malassezia could be due to differences in methodology. However, an alternative 
explanation is that dysbiosis is present at the species level in allergic dogs. Findley et al. found 
that even though Malassezia was the predominant commensal across all body sites, excluding the 
feet, species level predilections existed between different body sites.63 It has been thought that 
M. pachydermatis is the predominant Malassezia commensal on canine skin. We wanted to 
investigate whether other species of Malassezia might be present on canine skin using NGS, and 
if species level dysbiosis might be occurring on allergic canine skin. Previous culture-dependent 
studies have isolated lipid dependent Malassezia from canine and feline skin,136,138,166-168 
supporting our suspicion that other species may be present. 
 Another yet unexplored facet of canine atopy is how the mycobiota, especially 
Malassezia, are affected by flares of inflammation. Interaction between the mycobiota and host 
immune system has recently been documented, prompting more investigations into the role of 
mycobiota in inflammatory conditions.25,60,67,169,170 Both atopic people and dogs have been 
shown to be hypersensitive to Malassezia by patch testing,98,171 providing more evidence that 
specifically Malassezia is interacting with the host immune system in inflammatory skin 
conditions. Multiple longitudinal studies have shown that Staphylococcus increases during atopic 
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flares in dogs,85,158 but our previous fungal NGS study only looked at the skin of allergic dogs 
who were not experiencing flares of inflammation and did not have any skin lesions.  
 To address these questions we performed phylogenetic analysis on the Malassezia 
sequences from the aforementioned NGS study of healthy and non-lesional allergic dogs to 
derive species level classification of sequences. To confirm the results, we additionally 
performed realtime quantitative PCR (qPCR) targeting specific species of Malassezia. 
Secondarily we performed the same analyses on skin swabs from a laboratory colony of 
inducible atopic dogs in a longitudinal study of allergen induced atopic lesional flares.  
Materials and Methods 
Study subjects 
 Client owned dogs were enrolled into the healthy (n=10) and non-lesional allergic (n=8) 
groups.134 The healthy dogs ranged in age from 1.5 to 11 years old, and included 5 spayed 
females and 5 castrated males. The allergic dogs ranged in age from 2 to 10 years old, and 
included 4 spayed females and 4 castrated males. The cause of allergies varied in these dogs 
including cutaneous adverse food reactions, flea allergy dermatitis, environmental atopy, and 
combinations. Inclusion criteria included a documented history of allergies diagnosed by a board 
certified dermatologist. Exclusion criteria included receiving antibiotics in the last month, and 
having been bathed in the last week. Body sites sampled in both the healthy and allergic groups 
included axilla, ear canal, groin, interdigital space, lumbar and nostril. 
 Purpose bred maltese-beagle dogs were included in the lesional atopic group (n=8).85 
These dogs had been previously exposed to and challenged with Dermatophagoides farinae 
house dust mite (HDM). They ranged in age from 2 to 14 years old and included four intact 
females, two spayed females, and two intact males. Exclusion criteria included receiving 
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antimicrobials, anti-inflammatory or immunosuppressive drugs in the last three months. Dogs 
were exposed to HDM daily for three days and skin swabs were taken prior to HDM application 
(1), at lesion development (2), and after lesion resolution (3). These dogs were under the care of 
and scored by a board certified veterinary dermatologist.  
Sample collection and DNA extraction 
 All skin swabs included in this study had previously been collected and DNA extracted as 
described.85,134 Briefly, sterile swabs (Isohelix,Cell Projects Ltd. UK) were rubbed on the skin 
for a total of 20 times and placed in a sterile microcentrifuge tube that was stored at 4C until 
extractions performed. Genomic DNA was extracted from skin swabs using a commercially 
available kit (MoBio Power Soil DNA Isolation kit, Carlsbad, CA). Negative controls included 
swab only and reagent only samples. Samples were stored for short term at -20C and long term at 
-80C.  
NGS and bioinformatics  
 Fungal DNA from client owned healthy and allergic dogs was sequenced as previously 
described.134 Fungal DNA from atopic dogs was presently amplified using ITS1 and ITS2 
primers, with 40 cycles and sequenced on an Illumina MiSeq instrument (2x 300) at the 
University of Minnesota Genomics Center. Mothur9 and the Findley et al. 2013 database were 
used to classify sequences to the genus level according to their recommended guidelines.63 
Briefly, sequences were quality filtered based on quality score threshold of 25, chimeric 
sequences removed, and k-nearest neighbor algorithm used to classify sequences. Next, 
Malassezia sequences were extracted in mothur, aligned to a Malassezia reference tree in 
pplacer172 using a reference package kindly supplied by the Segre lab, and species level 
taxonomic strings exported using the guppy command. New taxonomic files were imported back 
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into mothur for further downstream analysis including making taxa plots by body site, time point 
and group.  
Realtime quantitative PCR  
 M. globosa (MYA-4612) and M. restricta (MYA-4611) ATCC strains and a clinical 
isolate of M. pachydermatis from a dog were used for standard curves. All strains were grown on 
modified Dixons agar for 2-7days at 32C. Plates were scraped and Power soil kit used to extract 
genomic DNA. Concentrations of DNA were measured in duplicate using Qubit high sensitivity 
kit on an CFX Connect Real-Time System (Bio-Rad Laboratories Inc., Hercules, CA) 
instrument. ITS-1 PCR and conventional sequencing was performed to confirm identification of 
all standards (data not included). Primers were previously published173 and included a common 
forward primer (ITS-ANA-F), and three reverse primers specific to each species targeted 
(GlobR, RestrR, PachyR). These primers were chosen because they target the ITS region which 
enables a consistent comparison with the NGS data, and were previously shown to be species 
specific.173 Standard curves consisted of five to six serial dilutions depending on the limit of 
detection for each primer pair. All standards, non-template controls, and samples were run in 
duplicate on a CFX Connect Real-Time System (Bio-Rad Laboratories Inc., Hercules, CA)  
instrument. Reactions consisted of 5ul Super mix, 0.5ul forward primer, 0.5ul reverse primer, 2ul 
water, and 2ul standard or sample for a total volume of 10ul. Cycle parameters were identical for 
all three qPCRs: initial heating step at 98C for 3 min, and 40 cycles of 95.0C for 30 second and 
60C for 30 seconds. Genome equivalents were calculated from the nanogram:Cq curve using 






 NGS relative abundances and qPCR genome equivalents were tested for normality using 
JMP Pro 14 software (SAS Institute, Inc.) and the Shapiro-Wilk test.  All data was confirmed to 
be non-normal and Kruskal-Wallis, a non-parametric test, was chosen for subsequent analysis. A 
significance value of p<0.05 was selected for all statistical tests. Relative abundances and 
genome equivalents were tested for significant differences between individual dogs, body sites, 
time points (inducible atopic dogs- time points 1, 2 and 3), and groups (healthy, non-lesional 
allergic, inducible atopic). When testing for differences between the client-owned dogs and the 
inducible atopic dogs, only the groin samples of healthy and allergic dogs were included for a 
more accurate comparison. A Steel-Dwas All Pairs, non-parametric, test was used for 
determining significance between pairs of individuals, body sites, time points, or groups.  
Results 
Malassezia populations of client-owned healthy and non-lesional allergic dogs 
NGS 
 Extraction of Malassezia sequences from the NGS dataset including 108 samples from 
six body sites on 10 healthy dogs and 8 non-lesional allergic dogs yielded 151,793 sequences 
with an average of 1,405 sequences per sample.  The main three Malassezia species represented 
in order of decreasing relative abundance were M. restricta (range: 0-99.2, mean=43.6), M. 
pachydermatis (range: 0-99.9, mean=40.9), and M. globosa (0-99.1, mean=7.7). Kruskal-wallis 
testing demonstrated that M. pachydermatis was significantly increased on allergic skin 
(p=0.0005), while M. restricta (p=0.0369) and M. globosa (p<0.0001) were significantly 
increased on healthy skin (Figure 14). Body site was not an influencing factor for either healthy 




Figure 14. Malassezia species level relative abundances in client owned healthy and non-lesional 
allergic dogs. Significant differences between health statuses are denoted by asterisks (*p<0.05, 
**p<0.01, ***p<0.001). a) Mean relative abundances of Malassezia species were calculated for 
client owned study groups including samples from all body sites and individuals. b) Mean 
relative abundances across all body sites were calculated for each individual dog. Relative 





 Species specific quantitative PCRs were performed for M. pachydermatis, M. restricta 
and M. globosa on all 108 healthy and non-lesional allergic dog samples. Genome equivalents 
were determined by a nanograms:Cq ratio, calculated using DNA concentration of the culture-
derived standards and the genome size of these three species. Overall M. restricta (range: 0-
3876, mean=75) was the most abundant by this method, followed by M.pachydermatis (range: 0-
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244, mean=5) and lastly M. globosa (range: 0-213, mean=3). Kruskal-wallis testing 
demonstrated that M. globosa was significantly increased on healthy skin (p<0.0001, Figure 15). 
Genome equivalents of M. restricta was increased on healthy skin but this finding was non-




Figure 15. Genome equivalents of M. globosa, M. restricta, and M. pachydermatis by health 
status. Genome equivalents of a) M. globosa, b) M. restricta, and c) M. pachydermatis were 
compared between client-owned healthy and allergic dogs. Significant differences between 




 In addition to health status, M. restricta was found to significantly vary by body site in 
both healthy and allergic dogs (Figure 16). Body site was not an influencing factor on genome 




Figure 16. Genome equivalents of M. restricta by qPCR varies by body site in both a) healthy 




 The individual dog was also identified as an influencing factor on genome equivalents of 
M. restricta and M. pachydermatis (but not M. globosa) for both healthy and allergic dogs 
(Table1).  By Kruskal-Wallis testing, the individual was identified as the strongest influencing 
factor, followed by group, and lastly by body site. Correlation between NGS and qPCR existed 







Table 4. Correlation of client-owned healthy and allergic dog findings between two methods- 
NGS and qPCR. Significant differences between groups (health status, body site, individual) are 





NGS            qPCR 
M. globosa  
NGS            qPCR 
M. pachydermatis 
NGS            qPCR 
Healthy v Allergic * - *** *** *** - 
Healthy body sites - ** - - - - 
Allergy body sites - * - - - - 
Healthy individual  ** * ** - *** ** 
Allergic individual - - - - - *** 
  
 
Malassezia populations during atopic lesion flares of inducible laboratory dogs 
NGS 
 Fungal NGS was performed on a colony of laboratory dogs for the first time and 24 
samples yielded 2,108,463 sequences. Extraction of Malassezia sequences from the NGS dataset 
including 24 samples of 8 laboratory dogs over three time points yielded 845,038 sequences with 




Figure 17. Relative abundance of fungal genera in eight inducible atopic laboratory dogs. The 
mean relative abundance of Malassezia species for each dog prior to HDM exposure are 
presented in a taxa plot. All other fungal genera sequenced from each sample are not portrayed to 




 Kruskal-wallis testing demonstrated that Malassezia genus relative abundances (range: 
9.5-99.7, mean=40.8) were significantly different between individual dogs (p=0.0267, Figure 









 The Malassezia species represented in order of decreasing relative abundance were M. 
pachydermatis, M. restricta, M. obtusa, M. furfur, M. globosa, M. slooffiae and M. sympodialis 





Figure 19. Malassezia species relative abundances in eight inducible atopic dogs. All dogs are 
grouped based on the change in M. pachydermatis elicited by HDM exposure- increasing (group 
A), or decreasing (group B), relative abundance. Each row within a group corresponds to one 
dog, and the three bars represent each time point sampled. Relative abundance in this plot is a 




 M. pachydermatis and M. restricta were considered the most abundant species, while the 
mean relative abundance of all other species was less than 5%. Kruskal-wallis testing 
demonstrated that species relative abundance significantly varied by individual but not time point 






Table 5. Correlation of inducible atopic dog findings between two methods- NGS and qPCR. 
Significant differences between groups (individual and time point) are denoted by asterisks 





Malassezia M. pachydermatis M. restricta 
NGS NGS  qPCR NGS  qPCR 
Individual * - ** * - 
Time - - - - - 
 
 
 Looking only at M. pachydermatis, there were two overall trends of increasing (Group A) 
or decreasing (Group B) relative abundance following HDM exposure. Kruskal- wallis testing 




Figure 20. Two trends following exposure to HDM- increasing or decreasing relative abundance 





 Species specific quantitative PCRs were performed for M. restricta (range 6-160, 
mean=55) and M. pachydermatis (range: 0-252, mean=39) on all 24 laboratory dog samples. 
Neither species were found to vary significantly between time points by this method. Individual 
was a significant influencing factor on genome equivalents of M. pachydermatis (Table 5, 
Supplementary table S18).   
 Comparison of genome equivalents between all three study groups (client-owned healthy 
groin, client-owned allergic groin, pre-HDM exposure groin) demonstrated that M. 
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pachydermatis was significantly increased by 8-fold on laboratory dogs (Figure 21).  M. restricta 




Figure 21. Comparison of M. pachydermatis and M. restricta genome equivalents across three 





 For the first time we have examined cutaneous Malassezia species populations in dogs 
using NGS and qPCR. One of the most significant findings from this study is that healthy canine 
skin is predominated by lipid-dependent yeast M. restricta and M. globosa. To our knowledge 
these yeast have not been previously isolated from dogs, but studies using NGS identified them 
as the predominant yeast on healthy human skin. Possible explanations for why this yeast has not 
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previously been isolated from canine skin are that M. globosa is a rather fastidious organism to 
culture in the laboratory, not assimilating any of the tween reagents in contrast to other species in 
this genus,174 and is not routinely looked for in dogs. Cafarchia et al. found that lipid dependent 
yeast were more commonly isolated from healthy canine skin compared to allergic skin, but the 
species identification was not carried out.167 Realtime quantitative PCR corroborated our 
phylogenetic analysis on NGS data showing that M. globosa was significantly more abundant on 
healthy canine skin and nearly absent on the skin of dogs with diagnosed allergies.  
 Increased abundances of M. globosa on healthy canine skin is of particular interest 
because recently researchers have concluded this yeast may play a  beneficial role to the host.175 
These authors found that M. globosa secretes an aspartyl protease with antibiofilm activities 
against Staphylococcus aureus, a known opportunistic pathogen in human atopic dermatitis 
flares. It is not known whether M. globosa secretes a protease that has similar action on S. 
psuedintermedius, the opportunistic pathogen in canine atopic dermatitis, but it is tempting to 
speculate how M. globosa may also play a protective role in healthy canine skin. Furthermore, its 
absence on atopic canine skin might contribute to secondary Staphylococcus infections that are 
frequently observed clinically in these patients.  
 Skin lipid content is known to be altered in canine atopic dermatitis122,176 and might 
explain why M. globosa, with very strict lipid dependency, thrives on healthy skin but not atopic 
skin. This particular dysbiosis might provide a niche for M. pachydermatis with a more versatile 
ability to metabolize a broader range of lipids177 and contribute to its overgrowth on atopic 
canine skin. A recent lipidomics assay demonstrated that triglyceride content is significantly 
more abundant on the forehead of healthy individuals where Malassezia predominates as a 
fungal commensal compared to the feet where the diversity of fungal commensals is much 
 
 91 
greater.178 Future studies performing simultaneous analysis of skin lipidomics and fungal 
microbiota in healthy and allergic dogs may offer more evidence for this idea that skin lipid 
content influences which yeast are the abundant commensals. 
 We previously identified Malassezia as being on average 6% of the skin mycobiota in 
healthy and allergic dogs, but presently found that laboratory inducible atopic dogs have an 8 
fold increased relative abundance of Malassezia on their skin. A variety of factors may 
contribute to this phenomenon. This colony of dogs is highly genetically related, and recent work 
has shown that the breed or genetic makeup of an animal has an influence on their skin 
microbiota.152,179 Additionally, these dogs are kept mostly indoors with increased humidity and 
greater hygiene compared to client-owned animals. It has been proposed that hygiene could play 
a significant factor in why people harbor more Malassezia on their skin compared to dogs and 
cats that have greater exposure to the environment and decreased hygiene practices.81 Lastly, as 
part of this colony’s animal welfare regimen, these dogs are fed a diet supplemented with fatty 
acids that have been shown to have anti-inflammatory effects and enhance the skin barrier in 
atopic dogs.  
 The sequencing of M. obtusa only from the laboratory dogs is also interesting and one 
other potential cause for differences between these two cohorts is that the client-owned animals 
were all from Texas, USA while the laboratory dogs are housed in North Carolina, USA. 
Geographic restriction may possibly exist in this genus given that M. japonica and M. 
yamatoensis are commonly isolated in SE Asia but not elsewhere.20 Geographic influence on the 
skin and gut microbiome was recently reviewed by Gupta et al. and found to be a significant 
factor in shaping the presence of commensals.28 Future comparisons of skin Malassezia 
populations should consider the location of individuals sampled when drawing conclusions about 
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the presence and distribution of these species. The three main species across all study groups 
regardless of location were M. restricta, M. pachydermatis, and M. globosa indicating a potential 
role of commensalism for these three species on canine skin.  
 Although we were mainly interested in studying populations of species within a genus, 
and have discussed a lot of potential inter-microbial and host-microbial interactions, the 
individual pathogen virulence must also be considered. The common etiologic agent of 
secondary Malassezia infections in allergic dogs is specifically M. pachydermatis. Phospholipase 
activity has been associated with increased virulence of M. pachydermatis strains causing otitis 
externa compared with strains from healthy animals. Furthermore, strains from dogs and cats 
differ in their abilities to form biofilms. 180 These strain-associated virulence factors should be 
further investigated in the context of the entire mycobiota of affected animals, as well as in 
conjunction with lipid content of the skin. It remains unclear why M. pachydermatis, generally 
the most virulent of all species in this genus, colonizes the skin of dogs but not people.  
 Canine atopic dermatitis can have variable presentations which has been attributed to its 
multifactorial pathogenesis.74 The prevalence of Staphylococcus pyoderma or Malassezia 
dermatitis in allergic dogs is not currently known. For some dogs these will occur 
simultaneously, but in other dogs their disease will be predominated by one or the other. There 
were clear alterations to the abundance of Malassezia species in client owned allergic dogs 
which may indicate a widespread predisposition to Malassezia dermatitis in allergic dogs. 
However, changes to Malassezia during flares of inflammation as assessed by the longitudinal 
study of laboratory inducible dogs was less clear. We identified two trends following exposure to 
allergen- increasing or decreasing abundances of M. pachydermatis.  These trends could explain 
why some allergic dogs are more prone to Malassezia dermatitis than others. However, there 
 
 93 
were very few dogs sampled in this study and future studies with larger numbers of animals 
would be needed to clarify this phenomenon. We also found that the individual was a strong 
influencing factor on the Malassezia populations which could have contributed to the variability 
in changes observed following allergen exposure. Importantly, the laboratory dogs did indeed 
harbor more M. pachydermatis compared to the client-owned healthy dogs which would support 
the conclusions that increased abundances of M. pachydermatis are present on allergic canine 
skin and predisposes them to Malassezia dermatitis. Future longitudinal studies of Malassezia 
populations during flares of inflammation might benefit from simultaneous investigation of the 
bacterial microbiota, skin lipid content, and other host factors such as TEWL and history of 
Malassezia dermatitis.  
 Interestingly, individual was a strong influencing factor for all three study groups. This 
was evident in that 1) some dogs would harbor more Malassezia across all body sites compared 
to other dogs 2) Malassezia abundances on laboratory dogs demonstrated similarity across 
longitudinal time points for individual dogs. The latter finding indicates there may be stability of 
Malassezia abundances over time, however these time points were over the course of 7-10 days 
and future studies with longer intervals would be needed to clarify this. Other temporal studies of 
the skin microbiome have found that there is stability at the species and strain levels.18 Body site 
was only an influencing factor for M. restricta abundances, however, this was the most abundant 
species across all study groups. Previous culture-independent studies also found that Malassezia 
populations varied between body sites.167 This might be explained by differences in lipid content 
of body sites, however this has not been described for canine skin. 
 Advantages and limitations exist for both culture-dependent and -independent techniques. 
Studies are underway to determine the exact lipid preferences of each Malassezia species and 
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may lead to development of more robust culture methodologies. Currently with such vast 
differences in the ability of Malassezia spp. to grow in culture, quantitatively comparing the 
relative abundances of Malassezia species between samples is nearly impossible. Molecular 
methods offer an advantage for mycobiota studies, however, we still do not know the exact 
biases introduced by copy number variation in the ITS region, primer efficiencies or 
contaminating fungal DNA.59 Upon publishing complete Malassezia genomes, Dawson and 
colleagues were able to show that some reports of Malassezia in metagenomic datasets was 
likely inaccurate.19 Future studies using metagenomics might better confirm the results presented 
in this study, however, corroboration between NGS and qPCR supports our conclusions.  
 The results in our study clearly show Malassezia spp. dysbiosis occurs in allergic dogs 
that are more predisposed to develop Malassezia infections and redefine our existing knowledge 
of healthy Malassezia populations. Harnessing this canine model of atopy, we have an animal 
model to further investigate interactions between skin microbiota, such as between Malassezia 
and Staphylococcus. Malassezia act as an opportunistic pathogen in a variety of human 
conditions including Pityriasis versicolor, dandruff and seborrheic dermatitis. Sheynius and 
colleagues recently showed that Malassezia interacts with the host via nanovesicles and may be 
contributing to inflammation in the host.181 It is unknown whether this mechanism may also 
occur in allergic dogs but the identification of M. globosa on healthy canine skin indicates that 
dogs would be an appropriate animal model for future studies. Finally, this canine model could 
serve as an opportunity to study how different therapeutic interventions affect the mycobiota in 






CHAPTER V  
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 The work presented in this thesis represents the seminal studies of skin mycobiota in 
veterinary medicine. We applied NGS for the first time to describe the healthy skin mycobiota of 
dogs and cats and identified a greater diversity of fungi than was previously shown with culture. 
Environmental fungi were predominant on both canine and feline skin, unlike human skin that is 
predominated by one genus, Malassezia. We identified dysbiosis of the skin mycobiota 
associated with inflammatory skin disease of dogs and cats which was characterized by an 
overall decreased diversity. The final chapter is moving us from description to pathogenesis 
through identification of dysbiosis at the species level that can be explained by altered lipid 
content in allergic skin. These works lay the foundation for future investigation into the 
mechanisms underlying the overgrowth of M. pachydermatis on allergic skin and animal models 
to test novel pre-biotics.  
 These foundational studies raised more questions regarding the temporality of fungi 
sequenced from skin swabs of animals. It remains unclear whether the environmental fungi 
sequenced were transient mycobiota or stably colonized on the skin surface. The hair coat of 
dogs and cats has been likened to a mop that collects fungal spores from the environment it 
contacts. Even though spores may only be transiently present on the hair coats of animals they 
may still be interacting with the host immune system in a significant way. Future studies 
sampling both shaved and unshaved animal skin over time may provide insight into the existence 
of a stable core microbiome versus transient colonizers. Decreased hygiene practices may also 
contribute to the presence of transient mycobiota that are less likely to be sampled on human skin 
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that is washed frequently. Two recent large scale studies concluded that hygiene and 
environmental exposure are strongly influencing factors on the skin microbiome. Mode of 
subsistence was identified as a geographic stratifier, where people with greater exposure to the 
environment (hunter-gatherers) had more diverse skin microbiota compared to western 
civilizations.28 Non-human mammals also were shown to have a more diverse skin microbiota 
compared to people with obvious increased hygiene practices.81 Future studies involving hair 
clipping or bathing frequency can also have clinical implications in veterinary dermatology for 
management guidelines on treating recurrent skin infections.  
 The presence of lipid dependent Malassezia as dominant commensals on healthy canine 
skin is demonstrated for the first time using NGS and confirmed by secondary primers and 
quantitative  PCR. These results could have important implications for both understanding 
disease pathogenesis and pursuing novel therapeutics such as a lipid pre-biotics that promote the 
growth of lipid dependent healthy commensals. NGS was a superior method to culture due to the 
striking differences in ability to culture these Malassezia species precluding the use of culture to 
quantitatively compare Malassezia populations between samples. That being said, culture will be 
a valuable next step for studying lipid preferences of M. restricta and M. globosa in vitro. 
Additionally, competition assays between Malassezia species and studying the effects of these 
species on Staphylococcus pseudintermedius biofilms will also be important in elucidating more 
details regarding the pathogenesis of secondary infections in allergic dogs.  
 While NGS has proven to be a valuable technique, we are still unsure of all the biases 
introduced by NGS of the ITS region in mycobiome studies. The ITS region has been shown to 
vary in copy number between fungal genera182,183 which could introduce bias into relative 
abundances within one sample, but should not affect the comparison of populations between 
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study groups or over time following treatment. To date there is not a clear consensus on whether 
ITS-1 or ITS-2 is the preferred target due to primer biases66,184 and future studies employing 
metagenomic sequencing would help to confirm findings from this thesis work. Other gene 
targets such as Beta-tubulin or Chitin synthase-2 may prove to be more accurate in studying 
animal skin mycobiota or specifically Malassezia species populations. Metagenomics would also 
be valuable in studying inter-microbial interactions as a result of treatment or prevention 
regimens used for allergic dermatitis in veterinary medicine. Metagenomics studies of human 
skin has have also been harnessed to study the overall function of the skin microbiome regardless 
of taxonomic classifications.185,186 
 Treatment effect on the skin microbiota has only recently been investigated in human 
medicine. Grice and colleagues looked at the effect of topical antimicrobials and antiseptics. 
They found that antimicrobial use resulted in a shift in resident bacterial communities that are 
thought to be protective against Staphylococcus aureus colonization, whereas antiseptics only 
resulted in minor shifts. This can obviously have very important clinical implications in the 
treatment of dermatologic conditions. They also concluded there is a stable and resilient skin 
microbiome with certain taxas such as Propionibacteria being most resilient. Segre and 
colleagues have recently tested the effects of emollients in prevention of atopic dermatitis in 
infants and found that emollient use promoted the growth of Streptococcus salivarius, a known 
beneficial commensal with anti-inflammatory effects. The increasing prevalence of antibiotic 
and antifungal resistance in both human and veterinary medicine is an important motivating 
factor for pursuing alternative approaches to preventing and treating skin infections. Future 
studies in veterinary medicine should include testing antiseptics and emollients on the skin of 
dogs and cats.  
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 Canine and feline allergic dermatitis are multifactorial diseases which include host 
factors such as skin barrier impairment and immune dysregulation. More studies are needed to 
understand the genetic contributions to these phenomena. In-breeding of animals has shown to 
introduce strong hereditary contributions to other diseases.187,188 Strong breed predilections exist 
for canine atopic dermatitis74 and more GWAS studies could help to identify genetic mutations 
contributing to disease pathogenesis. These genetic contributions to skin barrier and immune 
dysregulation could also have effects on the skin microbiota and ultimately treatment success. As 
such, these are important in stratifying participants of future microbiome studies testing these 
effects. The most robust studies would include both genetic, physical skin barrier, immune 
system and microbiota evaluations simultaneously.  
 Progress has quickly been made in the study of the canine gastrointestinal microbiome 
over the last decade. Leading research groups have quickly moved beyond the study of bacterial 
microbiota to the functional aspects of dysbiosis such as bile acid metabolism.189,190 We hope to 
move the study of the skin microbiome in veterinary medicine similarly to investigate the 
functional aspects of dysbiosis in dermatologic conditions. Specifically lipidomics could provide 
revolutionary insight into the presence and distribution of skin commensals on healthy and 
allergic canine skin. These studies might also direct us towards the development of pre-biotics 
that include specific proportions of triglycerides that favor the growth of healthy commensals 
and prevent the overgrowth of virulent opportunistic pathogens like Malassezia pachydermatis. 
We have recently tested the effect of an essential oil and essential fatty acid topical product on 
the skin of bloodhounds, and found that by qPCR the abundance of Malassezia increased after 
weekly application.191 We have not carried out species identification yet for these samples, but 
 
 99 
these results do demonstrate the potential for topicals to influence the composition of the 
mycobiota.   
 Descriptive studies were our initial goal of the works presented in this thesis, but our 
findings have quickly propelled us forward into investigations of functionality of skin mycobiota 
in canine allergic dermatitis. Importantly, recent studies have reproduced our results lending 
accuracy to these findings.87,192 These and future studies may change the way we approach 
treatment or prevention of secondary infections in allergic dogs. Other yet unexplored effects of 
these results are how the skin mycobiota of companion animals influence the skin microbiota of 
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Supplementary table S1. Overall effect of body site, dog, and health status on alpha diversity. 
Fungal richness was estimated with observed species and Chao1 in Mothur, fungal diversity was 
estimated using the non-parametric Shannon and Inverse Simpson in Mothur, and overall effect 
of body site, dog and health status was calculated with Kruskal-Wallis tests performed in JMP. 
P-values are listed for each factor on each group of samples  including healthy only body sites, 
allergic only body sites, and body sites shared between health status groups (Meason-Smith, 
2015). 
Group Factor Observed Species Chao1 Shannon Inverse Simpson 
Healthy 
Body Site 0.0002 0.0004 0.0283 0.1380 
Dog <0.0001 <0.0001 0.0003 0.0088 
Allergic 
Body Site <0.0001 0.0030 0.0297 0.1657 
Dog 0.9480 0.8437 0.0900 0.0455 

























Supplementary table S2. Alpha diversity calculations by site in healthy skin group. Fungal 
richness was estimated with observed species and Chao1 in Mothur, and fungal diversity was 
estimated using the non-parametric Shannon and Inverse Simpson in Mothur. The median, 




Observed Species Chao1 Shannon Inverse Simpson 
Median Min-Max Median Min-Max Median Min-Max Median Min-Max 
Axilla 46 24-87 66 40-140 1.9 1.3-2.4 1.9 2.1-6.4 
Conjunctiva 26 18-41 40 29-55 1.8 1.5-2.3 1.8 3.1-6.8 
Dorsal Nose 51 23-110 75 40-157 2.0 1.5-2.7 2.0 2.6-5.7 
Ear 37 20-71 52 32-88 2.2 1.7-3.1 2.2 3.3-10.0 
Groin 44 21-89 63 36-135 2.1 1.5-2.6 2.1 3.0-6.8 
Interdigital 43 25-86 64 40-116 1.9 1.3-2.4 1.9 1.9-7.0 
Lip 49 23-110 68 40-151 2.0 1.4-2.6 2.0 2.9-6.6 
Lumbar 39 11-54 56 19-73 1.9 0.1-2.6 1.9 1.0-8.5 
Nostril  24 16-41 41 30-54 1.2 0.2-2.1 1.2 1.1-5.5 














Supplementary table S3. Alpha diversity calculations by dog in healthy skin group. Alpha 
diversity calculations by dog in healthy skin group. Fungal richness was estimated with observed 
species and Chao1 in Mothur, and fungal diversity was estimated using the non-parametric 
Shannon and Inverse Simpson in Mothur. The median, minimum and maximum values were 




Observed Species Chao1 Shannon Inverse Simpson 
Median Min-Max Median Min-Max Median Min-Max Median Min-Max 
1 23 16-47 40 29-63 1.8 0.9-2.4 4.7 2.1-7.6 
2 24 11-44 40 19-58 1.6 0.1-1.9 3.7 1.0-4.5 
3  37 23-58 56 38-79 2.1 0.9-2.4 4.8 1.6-6.7 
4 36 22-48 51 34-70 2.0 1.2-2.2 4.1 2.5-5.4 
5 29 22-42 47 41-65 2.0 0.3-2.3 5.1 1.1-7.5 
6 39 23-58 53 32-87 2.1 1.6-2.4 4.9 3.0-6.8 
7 41 28-49 53 42-66 2.0 1.6-2.4 3.5 2.9-7.2 
8 45 19-89 61 43-135 1.9 0.2-2.6 3.8 1.1-6.3 
9  45 22-62 64 38-85 1.7 1.1-2.2 3.0 1.8-5.3 

















Supplementary table S4. Dissimilarity of fungal community membership and structure between 
dogs. The median R-value was calculated from R values only for comparisons that were 
significant. The minimum and maximum R-values for this subset of significant R-values were 
also calculated and reported within the table. ANOSIM was performed on distance matrices 
produced using the three beta diversity metrics on two groups of samples: healthy only and 
allergic only. If there were no significant comparisons then n/a was listed in the table. All P-
values were corrected using the FDR equation (Meason-Smith, 2015). 
 
  Healthy Dogs Allergic Dogs 
Bray 
Curtis 
Median  R  (min-max) 0.338 (0.11-0.667) 0.306 (0.176-0.559) 
Median P value (FDR) (min-max) 0.045 (0.003-0.049) 0.023 (0.016-0.036) 
Number of Significant Comparisons 
(total comparisons) 
38 (45) 11 (28) 
Jaccard 
Median  R  (min-max) 0.535 (0.147-0.836) n/a 
Median P value (FDR) (min-max) 0.045 (0.006-0.049) n/a 
Number of Significant Comparisons 
(total comparisons) 
23 (45) 0 
Theta YC 
Median  R  (min-max) 0.381 (0.108-0.954) 0.297 (0.178-0.683) 
Median P value (FDR) (min-max) 0.045 (0.004-0.049) 0.038 (0.019-0.04) 
Number of Significant Comparisons 
(total comparisons) 



















Supplementary table S5. Combined and filtered relative abundance table for 193 fungal taxa that 
were tested for significant differences between body sites, dogs, and health status. For each test, 
the Kruskal-Wallis P-values are listed in columns following the taxa names. Classification of 
each sample within body site, dog, and health status are found in rows above the sample 






















Ascomycota 0.0012 0.5617 0.1749 0.4812 0.9898 
Ascomycota_class_incertae_sedis 0.0350 0.4549 0.3241 0.6614 0.1631 
Ascomycota_order_incertae_sedis 0.0379 0.5118 0.4102 0.7441 0.1398 
Ascomycota_family_incertae_sedis 0.0305 0.5328 0.6147 0.7567 0.2343 
Dothideomycetes 0.0290 0.4073 0.1037 0.6580 0.9746 
Capnodiales 0.0000 0.1200 0.0543 0.5415 0.8457 
Capnodiales_family_incertae_sedis 0.0031 0.0669 0.3477 0.5351 0.4063 
Capnobotryella 0.6575 0.2633 0.9521 0.3389 0.0006 
Cladosporium 0.0080 0.0562 0.2259 0.5272 0.3215 
Dissoconium 0.0000 0.3329 0.6609 0.3989 0.2692 
Ramichloridium 0.0010 0.7842 0.9718 0.3233 0.0095 
Mycosphaerellaceae 0.0000 0.1038 0.1626 0.2639 0.7247 
Cercospora 0.0001 0.7459 0.6544 0.3082 0.8293 
Mycosphaerella 0.0027 0.3541 0.5455 0.3707 0.0014 
unclassified_Mycosphaerellaceae_gen
us 0.0000 0.1069 0.1623 0.3951 0.7128 
unclassified_Capnodiales_family 0.0351 0.0748 0.8141 0.2057 0.0019 
unclassified_Capnodiales_genus 0.0367 0.0936 0.8141 0.3214 0.0016 
Dothideales 0.0583 0.0348 0.7476 0.5865 0.9618 
Dothioraceae 0.0250 0.0354 0.9635 0.4691 0.7191 
unclassified_Dothioraceae_genus 0.0561 0.0589 0.9419 0.3625 0.3099 
Dothideomycetes_order_incertae_sedis 0.0446 0.9517 0.2221 0.7672 0.5571 
Dothideomycetes_family_incertae_sedis 0.0430 0.9251 0.2946 0.7615 0.6040 
Epicoccum 0.0452 0.9283 0.2946 0.7490 0.5575 
Pleosporales 0.0000 0.9630 0.2679 0.8058 0.5338 
Montagnulaceae 0.0037 0.7200 0.7616 0.7741 0.2930 
unclassified_Montagnulaceae_genus 0.0075 0.7516 0.6781 0.6744 0.1785 
Phaeosphaeriaceae 0.0174 0.4555 0.8601 0.7779 0.0006 
Pleosporaceae 0.0000 0.9220 0.2285 0.7720 0.0369 






















Cochliobolus 0.0001 0.7721 0.5482 0.4740 0.0000 
Exserohilum 0.0014 0.6062 0.7101 0.7086 0.0001 
Lewia 0.1398 0.7730 0.9998 0.7996 0.6724 
Stagonospora 0.0038 0.3333 0.3116 0.9419 0.9369 
Pleosporales_family_incertae_sedis 0.0000 0.4950 0.1313 0.7538 0.7531 
Ascochyta 0.0008 0.9336 0.0587 0.9941 0.1543 
Leptosphaerulina 0.4286 0.0666 0.9699 0.5129 0.3035 
Phoma 0.0000 0.7698 0.1896 0.6975 0.0968 
unclassified_Pleosporales_family 0.0000 0.9077 0.1283 0.2525 0.5199 
unclassified_Pleosporales_genus 0.0000 0.9145 0.1283 0.3156 0.4773 
unclassified_Dothideomycetes_order 0.0002 0.2754 0.2231 0.7278 0.0006 
unclassified_Dothideomycetes_family 0.0002 0.2504 0.2656 0.7464 0.0005 
unclassified_Dothideomycetes_genus 0.0002 0.2459 0.2324 0.7135 0.0005 
Eurotiomycetes 0.0000 0.5979 0.2456 0.1213 0.0092 
Chaetothyriales 0.0041 0.6878 0.7999 0.5146 0.0005 
Herpotrichiellaceae 0.0048 0.8447 0.9560 0.4630 0.0014 
unclassified_Chaetothyriales_family 0.0057 0.1468 0.8742 0.7677 0.0541 
unclassified_Chaetothyriales_genus 0.0059 0.1501 0.9518 0.7852 0.0516 
Eurotiales 0.0000 0.9337 0.2410 0.0928 0.0367 
Trichocomaceae 0.0000 0.9259 0.2812 0.1160 0.0349 
Aspergillus 0.0002 0.9243 0.2885 0.5112 0.2612 
Penicillium 0.0014 0.7607 0.9969 0.3440 0.0015 
unclassified_Trichocomaceae_genus 0.0003 0.9327 0.8712 0.5862 0.0001 
Lecanoromycetes 0.0017 0.2251 0.8360 0.4780 0.0244 
Leotiomycetes 0.0358 0.4503 0.1580 0.3347 0.0006 
Helotiales 0.0251 0.1977 0.2731 0.5594 0.4233 
Helotiaceae 0.3777 0.1135 0.4003 0.6162 0.7460 
Articulospora 0.0280 0.1036 0.3333 0.7147 0.2223 
Sclerotiniaceae 0.0046 0.6983 0.6894 0.7478 0.0002 
unclassified_Sclerotiniaceae_genus 0.0042 0.6609 0.6744 0.6816 0.0001 
Leotiomycetes_order_incertae_sedis 0.0147 0.4885 0.6958 0.8131 0.0000 
Erysiphaceae 0.0185 0.5353 0.7018 0.7601 0.0000 
Blumeria 0.0021 0.8089 0.7194 0.7962 0.0000 
Golovinomyces 0.0098 0.0475 0.6863 0.5598 0.0000 
Podosphaera 0.0010 0.7618 0.9999 0.7789 0.0890 






















Pezizales 0.0005 0.2627 0.5895 0.7260 0.0004 
unclassified_Pezizales_family 0.0001 0.4901 0.8877 0.7711 0.0002 
unclassified_Pezizales_genus 0.0001 0.4648 0.9641 0.6940 0.0002 
Saccharomycetes 0.0146 0.5894 0.0801 0.5224 0.1478 
Saccharomycetales 0.0135 0.6621 0.1803 0.5567 0.1108 
Saccharomycetaceae 0.0357 0.9158 0.3604 0.9771 0.0124 
Saccharomycetales_family_incerta_sed
is 0.0237 0.4405 0.1507 0.5682 0.0020 
Candida 0.0173 0.5950 0.1451 0.6395 0.0014 
Sordariomycetes 0.2881 0.3269 0.2731 0.1351 0.5468 
Glomerellales 0.0088 0.0188 0.9538 0.5077 0.0005 
Glomerellales_family_incertae_sedis 0.0002 0.4989 0.8363 0.7143 0.2873 
Plectosphaerellaceae 0.0046 0.0801 0.9423 0.4680 0.0004 
Plectosphaerella 0.0049 0.0916 0.9405 0.3716 0.0010 
Hypocreales 0.0087 0.2736 0.6133 0.0767 0.2805 
Bionectriaceae 0.0055 0.4392 0.8686 0.5152 0.1149 
Hydropisphaera 0.1597 0.3533 0.5457 0.4012 0.0033 
Clavicipitaceae 0.0001 0.6948 0.7772 0.1347 0.0002 
Claviceps 0.0000 0.7728 0.6874 0.2892 0.0002 
Hypocreales_family_incertae_sedis 0.0021 0.0962 0.6056 0.2733 0.8023 
Fusarium 0.0010 0.1086 0.7275 0.3775 0.3147 
Myrothecium 0.0164 0.1485 0.9756 0.3224 0.2075 
Sarocladium 0.0166 0.2437 0.1436 0.6888 0.4185 
unclassified_Hypocreales_family 0.0002 0.2341 0.4727 0.1742 0.0368 
unclassified_Hypocreales_genus 0.0002 0.2341 0.5252 0.2177 0.0335 
Microascales 0.0000 0.2532 0.2405 0.5063 0.0001 
Halosphaeriaceae 0.0000 0.7699 0.6194 0.5469 0.0000 
Periconia 0.0000 0.7812 0.6750 0.4625 0.0000 
Sordariales 0.0858 0.3011 0.4976 0.6379 0.1058 
Chaetomiaceae 0.2769 0.0766 0.8717 0.4957 0.2901 
Chaetomium 0.5055 0.0566 0.9395 0.3636 0.3267 
Sordariaceae 0.0214 0.7725 0.2388 0.5482 0.0120 
Gelasinospora 0.0134 0.8033 0.3318 0.3825 0.0081 
Sordariomycetes_order_incertae_sedis 0.0000 0.9384 0.1973 0.7177 0.0017 
Magnaporthaceae 0.0000 0.7571 0.1421 0.7803 0.6100 
Magnaporthe 0.0000 0.7337 0.1171 0.9354 0.9896 






















Sordariomycetes_family_incertae_sedis 0.0093 0.6970 0.4004 0.3548 0.0002 
Acremonium 0.0092 0.7437 0.4004 0.3411 0.0001 
Trichosphaeriales 0.9909 0.1596 0.7492 0.6001 0.3456 
unclassified_Sordariomycetes_order 0.1164 0.2628 0.7664 0.4912 0.0261 
unclassified_Sordariomycetes_family 0.1231 0.3212 0.8211 0.5668 0.0235 
unclassified_Sordariomycetes_genus 0.1231 0.3170 0.7983 0.3543 0.0202 
Xylariales 0.0005 0.4756 0.6538 0.5695 0.2086 
Amphisphaeriaceae 0.5628 0.2641 0.4741 0.4549 0.2571 
Pestalotiopsis 0.6466 0.3145 0.6994 0.3849 0.2654 
unclassified_Xylariales_family 0.2854 0.5063 0.8605 0.4542 0.0010 
unclassified_Xylariales_genus 0.2803 0.5063 0.9322 0.3650 0.0009 
Xylariaceae 0.0000 0.6987 0.5380 0.7173 0.7921 
unclassified_Ascomycota_class 0.0924 0.2859 0.8409 0.0596 0.4205 
unclassified_Ascomycota_order 0.0910 0.2859 0.7568 0.1341 0.4055 
unclassified_Ascomycota_family 0.0951 0.3064 0.8226 0.2235 0.4113 
unclassified_Ascomycota_genus 0.0963 0.2979 0.8446 0.2794 0.3877 
Basidiomycota 0.0009 0.8417 0.2303 0.3913 1.1801 
Agaricomycetes 0.0008 0.6656 0.1815 0.3777 0.9390 
Agaricales 0.0006 0.6864 0.9271 0.5457 0.1355 
Agaricales_family_incertae_sedis 0.0000 0.9116 0.6315 0.7417 0.1400 
Psathyrellaceae 0.0019 0.7344 0.5334 0.5467 0.2371 
Coprinellus 0.0712 0.7759 0.6878 0.3865 0.7973 
unclassified_Psathyrellaceae_genus 0.0007 0.7713 0.5526 0.7153 0.9682 
Schizophyllaceae 0.4748 0.9379 0.6039 0.9790 0.0002 
Schizophyllum 0.2798 0.9368 0.6672 0.9797 0.0002 
unclassified_Agaricales_family 0.0578 0.1806 0.6301 0.7298 0.0155 
unclassified_Agaricales_genus 0.0592 0.1736 0.6632 0.7057 0.0127 
Agaricomycetes_order_incertae_sedis 0.0003 0.6643 0.4680 0.9197 0.8748 
Corticiaceae 0.0004 0.8797 0.9479 0.7402 0.6067 
Peniophoraceae 0.0041 0.7819 0.8786 0.7335 0.8150 
Peniophora 0.0057 0.8152 0.7116 0.7399 0.9402 
Auriculariales 0.0000 0.9995 0.5531 0.5858 0.1068 
Cantharellales 0.0075 0.6450 0.7711 0.8314 0.0012 
Ceratobasidiaceae 0.4079 0.6024 0.5924 0.7751 0.7808 
Hydnaceae 0.0000 0.9972 0.3466 0.7771 0.0000 






















Polyporales 0.0005 0.7433 0.7418 0.7187 0.4230 
Polyporales_family_incertae_sedis 0.0032 0.7164 0.8215 0.7881 0.2861 
Irpex 0.0000 0.8087 0.7062 0.9227 0.0031 
Trametes 0.0979 0.5037 0.6774 0.3449 0.0305 
Basidiomycota_class_incertae_sedis 0.0008 0.6310 0.7988 0.4996 0.2759 
Basidiomycota_order_incertae_sedis 0.0007 0.7027 0.3742 0.7414 0.0003 
Basidiomycota_family_incertae_sedis 0.0009 0.7353 0.4252 0.7479 0.0002 
Cerinosterus 0.0002 0.8613 0.7108 0.5969 0.0000 
Wallemia 0.0000 0.8556 0.3587 0.7954 0.0022 
Entylomatales 0.0000 0.9982 0.4933 0.9688 0.0021 
unclassified_Entylomatales_family 0.0000 0.9508 0.5851 0.9733 0.0019 
unclassified_Entylomatales_genus 0.0000 0.9476 0.6206 0.9864 0.0016 
Malasseziales 0.0491 0.7898 0.5119 0.9775 0.3096 
Malasseziales_family_incertae_sedis 0.0484 0.7953 0.6003 0.9891 0.3000 
Malassezia 0.0502 0.7697 0.6331 0.9752 0.3043 
Pucciniales 0.1532 0.6740 0.2342 0.7959 0.0000 
Pucciniastraceae 0.0343 0.7176 0.1882 0.7643 0.0000 
Pucciniastrum 0.0360 0.7662 0.1177 0.7287 0.0000 
Sporidiobolales 0.0043 0.4381 0.7232 0.4927 0.0691 
Sporidiobolales_family_incertae_sedis 0.0027 0.4608 0.8307 0.5192 0.0366 
Rhodotorula 0.0485 0.3564 0.7740 0.4093 0.1312 
Sporobolomyces 0.0002 0.7595 0.3268 0.4636 0.0001 
unclassified_Sporidiobolales_family 0.2733 0.4264 0.9414 0.5908 0.0196 
unclassified_Sporidiobolales_genus 0.2662 0.3553 0.9779 0.5043 0.0163 
Tremellomycetes 0.0079 0.6093 0.3217 0.3105 0.1561 
Filobasidiales 0.9636 0.3700 0.2608 0.5012 0.2034 
Filobasidiaceae 0.9321 0.6890 0.3477 0.4594 0.2365 
Filobasidium 0.9321 0.7509 0.3431 0.3961 0.2094 
Tremellales 0.0005 0.7956 0.2591 0.4853 0.1108 
Tremellaceae 0.0037 0.5953 0.4053 0.7157 0.1233 
Tremellales_family_incertae_sedis 0.0056 0.6909 0.3334 0.4441 0.1037 
Cryptococcus 0.0042 0.7766 0.3561 0.4140 0.0837 
unclassified_Tremellales_family 0.0002 0.4065 0.8451 0.5855 0.7601 
unclassified_Tremellales_genus 0.0002 0.3455 0.8594 0.5053 0.7436 
unclassified_Basidiomycota_class 0.0046 0.4873 0.2681 0.9499 0.6863 






















unclassified_Basidiomycota_family 0.0044 0.4920 0.3351 0.9826 0.7065 
unclassified_Basidiomycota_genus 0.0043 0.5158 0.3427 0.9895 0.6723 
Ustilaginomycetes 0.0000 0.6175 0.8904 0.1708 0.3354 
Ustilaginales 0.0000 0.6385 0.8217 0.2609 0.3279 
unclassified_Ustilaginales_family 0.0000 0.7361 0.9735 0.3847 0.3609 
unclassified_Ustilaginales_genus 0.0000 0.7729 0.9876 0.3306 0.3308 
Ustilaginaceae 0.0000 0.7854 0.7909 0.3119 0.2873 
Pseudozyma 0.0001 0.7941 0.8725 0.4301 0.3832 
Sporisorium 0.0000 0.5984 0.4710 0.3324 0.0000 
unclassified_Ustilaginaceae_genus 0.0031 0.6630 0.4016 0.7883 0.3122 
Glomeromycota 0.1166 1.2023 0.8817 0.5524 0.4158 
Glomeromycetes 0.1244 0.4809 0.8817 0.4420 0.2661 
unclassified_Fungi_phylum 0.0003 0.4225 0.2804 0.6427 0.0412 
unclassified_Fungi_class 0.0003 0.6760 0.2243 0.5142 0.0264 
unclassified_Fungi_order 0.0002 0.6613 0.2524 0.5784 0.0247 
unclassified_Fungi_family 0.0002 0.6852 0.3059 0.5713 0.0215 
unclassified_Fungi_genus 0.0002 0.7369 0.3004 0.5211 0.0182 
























Supplementary table S6. Alpha diversity calculations by site in allergic skin group. Fungal 
richness was estimated with Observed species and Chao1 in Mothur, and fungal diversity was 
estimated using the non-parametric Shannon and Inverse Simpson in Mothur. The median, 
minimum and maximum values were calculated for each allergic body site (Meason-Smith, 
2015). 
Skin Site 
Observed Species Chao1 Shannon Inverse Simpson 
Median Min-Max 
Median 
Min-Max Median Min-Max Median Min-Max 
Axilla 34 20-52 48 42-69 1.8 1.4-2.3 3.6 2.7-6.2 
Ear 21 12-31 39 22-59 1.4 0.1-1.9 2.6 1.0-5.4 
Groin 27 23-47 48 43-56 1.9 0.3-2.5 3.7 1.1-7.5 
Interdigital 38 31-45 52 46-59 2.1 1.0-5.6 4.7 1.8-9.1 
Lumbar 27 21-37 47 31-63 2.0 1.2-2.4 4.8 2.5-7.4 






Supplementary table S7. Alpha diversity calculations by dog in allergic skin group. Fungal 
richness was estimated with Observed species and Chao1 in mothur, and fungal diversity was 
estimated using the non-parametric Shannon and Inverse Simpson in mothur. The median, 
minimum and maximum values were calculated for each allergic dog (Meason-Smith, 2015). 
Dog Number 
Observed Species Chao1 Shannon Inverse Simpson 
Median Min-Max Median Min-Max Median Min-Max Median Min-Max 
11 31 16-52 43 29-69 2.0 1.5-2.5 4.7 3.2-7.7 
12 31 20-43 42 37-54 2.1 1.4-2.3 5.1 2.6-6.2 
13  23 20-37 46 39-51 1.6 0.3-2.6 3.8 1.1-9.1 
14 26 21-45 49 38-59 1.6 0.4-2.6 3.1 1.1-7.5 
15 22 20-39 40 31-52 1.9 1.4-2.1 4.9 2.8-7.1 
16 31 16-40 47 32-56 1.4 0.7-1.5 2.6 1.5-3.1 
17 37 12-39 48 22-51 1.6 0.1-1.9 3.0 1.0-3.7 






Supplementary table S8. Dissimilarity of fungal community membership and structure between 
body sites. R values from global test of the factor body site performed with ANOSIM on 
distance matrices generated from only allergic body sites using the three beta diversity metrics 
Bray Curtis, Jaccard, and Yue-Clayton theta coefficient (mothur) were listed for significant 
comparisons (*P<0.05 after FDR correction). R values from global test of the factor health status 
performed with ANOSIM on distance matrices generated from only body sites shared between 
the two health status groups using the three beta diversity metrics Bray Curtis, Jaccard, and Yue-
Clayton theta coefficient (mothur) were listed for significant comparisons (*P<0.05 after FDR 
correction) (Meason-Smith, 2015).  
  Bray Curtis Jaccard Theta YC 
Allergic Dogs 
Axilla 0.331* 0.207 0.294* 
Groin 0.227 0.151 0.213* 
Interdigital 0.441* 0.176 0.300* 
Comparison of Shared 
Sites between Healthy and 
Allergic Dogs 
Ear 0.093 0.249* 0.092 
Groin 0.013 0.264* 0.052 














Supplementary table S9. Alpha diversity averages for healthy cats. Average values are listed 
with the standard deviation in parentheses (Meason-Smith, 2017).  
  
Chao1 Observed OTUs Shannon 
Body Site 
Axilla 625 (215) 121 (42) 3.07 (0.83) 
Chin 693 (219) 144 (56) 3.66 (1.18) 
Conjunctiva 430 (152) 92 (51) 1.36 (0.65) 
Dorsal Nose 764 (470) 146 (62) 3.95 (0.88) 
Dorsum 647 (187) 116 (26) 3.35 (0.76) 
Ear Canal 617 (150) 146 (32) 2.85 (1.33) 
Groin 681 (188) 158 (39) 3.17 (1.28) 
Interdigital 693 (127) 179 (49) 4.15 (0.60) 
Nostril 657 (255) 165 (40) 2.21 (0.98) 
Oral 754 (275) 163 (30) 3.81 (0.91) 
Preaural space 684 (321) 192 (44) 4.58 (0.93) 
Prepuce/Labia 730 (210) 137 (48) 2.01 (1.09) 
Cat 
C1 617 (251) 141 (32) 3.74 (1.00) 
C2 612 (216) 140 (37) 3.15 (1.41) 
C3 844 (605) 121 (13) 2.39 (1.08) 
C4 737 (207) 163 (28) 3.38 (1.02) 
C5 659 (258) 161 (46) 4.14 (1.20) 
C6 648 (188) 163 (52) 4.17 (1.62) 
C7 756 (201) 165 (41) 3.17 (0.88) 
C8 590 (341) 116 (30) 2.97 (1.10) 
C9 763 (115) 211 (48) 3.89 (0.93) 
C10 501 (162) 120 (44) 2.24 (0.92) 
C11 677 (73) 144 (29) 3.53 (0.97) 
Skin Physiology 
Haired 679 (269) 148 (47) 3.51 (1.04) 
Mucosal 585 (236) 120 (47) 1.96 (1.04) 
Oral 754 (275) 163 (30) 3.81 (0.91) 









Supplementary table S10. Average R statistic and range of P-values for 
significant pairwise comparisons (Meason-Smith, 2017). 
 
 Jaccard  Bray Curtis  Pearson  
  Factor  N  R  P-value  N  R  P-value  N  R  P-value   
Healthy Cat  20  0.223  0.003-0.025  19  0.215  0.003‐ 26  0.227  0.004- 
  0.038    0.041  
  
Skin Physiology  
1  0.282  0.003  1  0.317  0.003  1  0.316  0.003  
Allergic   Cat  2  0.413  0.041-0.050  6  0.37  0.041- 
0.041  
0  n/a  n/a  
N- number of significant pairwise comparisons
 
 126 
Supplementary table S11. Fungal taxa from filtered relative abundance table for healthy cat 




Supplementary Table S11. Continued  
 
 
Ave. Rel. Abund.- average relative abundance, Std. Dev. Rel. Abund.- average standard deviation of the relative abundance, N‐number of 
taxa included within the phylogentic level (class, order, family, genus), Kruskall-Wallis Stat.‐ Kruskall-Wallis statistic, DF-degrees of 
freedom, Adjusted P‐value- corrected with the Benjamini Hochberg equation.  
Average relative abundance and standard deviation calculated across all healthy cat samples. The 
number of taxa present within a level (e.g. phylum) that was used for Benjamini and Hochberg 
False Discovery Rate (FDR) correction listed, along with the adjusted P-value. P-values less than 





Supplementary Table S12. Alpha diversity averages for allergic cats. Average values listed with 
standard deviation in parentheses (Meason-Smith, 2017). 
 
Chao1 Observed OTUs Shannon 
Body Site 
      
Axilla 881 (288) 192 (36) 3.42 (0.49) 
Dorsum 1015 (249) 211 (44) 3.95 (0.99) 
Ear Canal 683 (166) 153 (32) 2.81 (0.94) 
Groin 764 (341) 225 (54) 3.52 (0.32) 
Interdigital 748 (285) 209 (31) 3.96 (0.77) 
Nostril 729 (153) 164 (48) 2.31 (0.85) 
Cat 
      
C12 729 (152) 179 (55) 2.99 (1.00) 
C13 742 (240) 204 (42) 3.87 (1.07) 
C14 775 (122) 212 (14) 3.41 (0.56) 
C15 535 (160) 164 (49) 3.42 (1.23) 
C16 941 (265) 223 (51) 3.86 (0.73) 
C17 797 (235) 210 (29) 3.87 (0.85) 
C18 1010 (480) 183 (79) 2.99 (0.57) 
C19 689 (146) 194 (43) 3.03 (0.63) 
C20 751 (114) 199 (51) 2.58 (0.68) 
Skin Physiology 
     
Haired 757 (274) 205 (43) 3.44 (0.73) 
Mucosal 729 (153) 164 (48) 2.31 (0.85) 
Steroid Usage 
     
Yes  766 (778) 211 (197) 3.46 (3.30) 













Supplementary table S13. Fungal taxa from filtered relative abundance table for allergic cat 
samples (Meason-Smith, 2017). 
 
Ave. Rel. Abund.- average relative abundance, Std. Dev. Rel. Abund.- average standard deviation of the relative abundance, N‐number of taxa 
included within the phylogentic level (class, order, family, genus), Kruskall-Wallis Stat.‐ Kruskall-Wallis statistic, DF-degrees of freedom, Adjusted 
P‐value- corrected with the Benjamini Hochberg equation.  
Average relative abundance and standard deviation calculated across all healthy cat samples. The number of taxa present 
within a level (e.g. phylum) used for Benjamini and Hochberg false discovery rate (FDR) correction listed, along with the 




Supplementary table S14. Global R statistics for beta diversity analysis for healthy and allergic 
cats (Meason-Smith, 2017). 
 Jaccard Bray Curtis Pear son 
Factor R P-value R P-value R P-value 
Healthy Cat 0.225 0.001 0.324 0.001 0.304 0.001 
Body Site 0.07 0.003 0.083 0.001 0.079 0.002 
Skin 
Physiology 
0.208 0.002 0.213 0.003 0.212 0.001 
Allergic Cat 0.364 0.001 0.324 0.001 0.304 0.001 
Body Site -0.048 0.806 -0.109 0.992 -0.104 0.988 
Skin 
Physiology 
0.073 0.225 0.208 0.047 0.233 0.031 

























Average relative abundance and standard deviation calculated across all samples that were included in the 
comparison between health statues (number of body sites sampled was six). The number of taxa present 
within a level (e.g. phylum) that was used for Benjamini and Hochberg False Discovery Rate (FDR) 





Supplementary table S16. Alpha diversity averages for health status (Meason-Smith, 2017).  
 
Chao1 Observed OTUs Shannon 
Healthy 666 (208) 150 (42) 3.20 (1.02) 
Allergic 657 (258) 141 (29) 3.26 (0.79) 
Values listed represent averages with standard deviations in parentheses 
 
Supplementary table S17.  Kruskal-wallis p values for relative abundance of Malassezia species 
between individual atopic dogs and between time points.  
NGS Individual  Time point 
Malassezia sp. 0.0070 0.9608 
M. furfur 0.0153 0.9115 
M. globosa 0.1853 0.3390 
M.obtusa 0.0095 0.934 
M. pachydermatis 0.2546 0.4317 
M. restricta 0.0437 0.8208 
M. slooffiae 0.1425 0.3432 
M. sympodialis 0.2914 0.9763 
M. yamatoensis 0.0251 0.9536 
 
Supplementary table S18.  Kruskal-wallis p values for genome equivalents of Malassezia species 
between individual atopic dogs and between time points.  
 
qPCR Individual  Time point 
M. pachydermatis 0.0063 0.9489 





Supplementary Figure S1 Results from comparison of two extraction protocols. (a) Relative 
abundances of Malassezia in the ear canal of five dogs were plotted in JMP with mean error bars. 
EP (Epicentre MasterPure Yeast Lysis Kit) signifies the samples extracted using the Findley et. 
al. 2013 protocol, and MB (MoBio) signifies the samples extracted following the Rodrigues et. 
al. 2014 protocol. (b) Stacked bar plot of predominant fungal taxa for each sample, grouped by 
dog number and extraction protocol. (c) PCoA plot of Bray Curtis calculated pairwise distances 







Supplementary Figure S2. Dissimilarity of fungal community membership between allergic 
dogs. PCoA plot of Bray Curtis calculated pairwise distances between body sites of only allergic 
dogs. The two dogs in red and blue cluster together and come from the same household. Each 







Supplementary Figure S3. Relative abundances of fungal taxa that were significantly different 








Supplementary figure S4. Relative abundance of Malassezia in healthy and allergic feline skin 
samples. The relative abundance of Malassezia is plotted for each skin sample from healthy and 
allergic cats. A-axilla, C-chin, CJ-conjunctiva, DN-dorsal nose, D-dorsum, EC-ear canal, G-








Supplementary figure S5. Alpha diversity of allergic cats. Alpha diversity estimated with 
Shannon diversity metric, and samples grouped by (a) cat, (b) body site, (c) skin physiology, and 
(d) steroids usage. Means and mean error bars are plotted in blue for each group. Groups with a 
mean significantly different from other means are denoted by asterisks, with associated P-values 





Supplementary figure S6. Beta diversity of allergic cats. PCoA plot of Bray Curtis pairwise 
distances for healthy cat samples, with associated ANOSIM global R statistic, and P-value; 











Supplementary figure S7. Relative abundance of Arthroderma and Fusarium in allergic feline 
skin samples. The relative abundance of (a) Arthroderma and (b) Fusarium is plotted for each 






Supplementary figure S8. LDA effect size (LEfSe) analysis of allergic cats. Fungal taxa that are 
significantly increased or decreased in allergic (a-b) cats or (c-d) body sites are presented in two 
forms- as bar blots showing the LDA score, and as a cladogram demonstrating the phylogenetic 
relationships. Taxa are colored according to cat or body site in which they are increased in 








Supplementary figure S9. Comparison of alpha diversity between healthy and allergic feline skin 
for six sites. Alpha diversity estimated with Shannon diversity metric, and samples grouped by 
(a) body site and health status, and (b) health status only, Means and mean error bars are plotted 
in blue for each group. Means were not significantly different for any group (Meason-Smith, 
2017).  
 
 
 
